<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:01:42Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4969571" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4969571</identifier><datestamp>2016-10-06</datestamp><setSpec>emboj</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">EMBO J</journal-id>
      <journal-id journal-id-type="iso-abbrev">EMBO J</journal-id>
      <journal-id journal-id-type="doi">10.1002/(ISSN)1460-2075</journal-id>
      <journal-id journal-id-type="publisher-id">EMBJ</journal-id>
      <journal-id journal-id-type="hwp">embojnl</journal-id>
      <journal-title-group>
        <journal-title>The EMBO Journal</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0261-4189</issn>
      <issn pub-type="epub">1460-2075</issn>
      <publisher>
        <publisher-name>John Wiley and Sons Inc.</publisher-name>
        <publisher-loc>Hoboken</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4969571</article-id>
      <article-id pub-id-type="pmcid">PMC4969571</article-id>
      <article-id pub-id-type="pmc-uid">4969571</article-id>
      <article-id pub-id-type="pmid">27334615</article-id>
      <article-id pub-id-type="pmid">27334615</article-id>
      <article-id pub-id-type="doi">10.15252/embj.201694401</article-id>
      <article-id pub-id-type="publisher-id">EMBJ201694401</article-id>
      <article-categories>
        <subj-group subj-group-type="overline">
          <subject>Article</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The C9orf72 protein interacts with Rab1a and the <styled-content style="fixed-case">ULK</styled-content>1 complex to regulate initiation of autophagy</article-title>
        <alt-title alt-title-type="left-running-head">Christopher P Webster <italic>etÂ al</italic></alt-title>
      </title-group>
      <contrib-group>
        <contrib id="embj201694401-cr-0001" contrib-type="author">
          <name>
            <surname>Webster</surname>
            <given-names>Christopher P</given-names>
          </name>
          <xref ref-type="aff" rid="embj201694401-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="author-notes" rid="embj201694401-note-0001">
<sup>â </sup>
</xref>
        </contrib>
        <contrib id="embj201694401-cr-0002" contrib-type="author">
          <name>
            <surname>Smith</surname>
            <given-names>Emma F</given-names>
          </name>
          <xref ref-type="aff" rid="embj201694401-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="author-notes" rid="embj201694401-note-0001">
<sup>â </sup>
</xref>
        </contrib>
        <contrib id="embj201694401-cr-0003" contrib-type="author">
          <name>
            <surname>Bauer</surname>
            <given-names>Claudia S</given-names>
          </name>
          <xref ref-type="aff" rid="embj201694401-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="embj201694401-cr-0004" contrib-type="author">
          <name>
            <surname>Moller</surname>
            <given-names>Annekathrin</given-names>
          </name>
          <xref ref-type="aff" rid="embj201694401-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="embj201694401-cr-0005" contrib-type="author">
          <name>
            <surname>Hautbergue</surname>
            <given-names>Guillaume M</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1621-261X</contrib-id>
          <xref ref-type="aff" rid="embj201694401-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="embj201694401-cr-0006" contrib-type="author">
          <name>
            <surname>Ferraiuolo</surname>
            <given-names>Laura</given-names>
          </name>
          <xref ref-type="aff" rid="embj201694401-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="embj201694401-cr-0007" contrib-type="author">
          <name>
            <surname>Myszczynska</surname>
            <given-names>Monika A</given-names>
          </name>
          <xref ref-type="aff" rid="embj201694401-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="embj201694401-cr-0008" contrib-type="author">
          <name>
            <surname>Higginbottom</surname>
            <given-names>Adrian</given-names>
          </name>
          <xref ref-type="aff" rid="embj201694401-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="embj201694401-cr-0009" contrib-type="author">
          <name>
            <surname>Walsh</surname>
            <given-names>Matthew J</given-names>
          </name>
          <xref ref-type="aff" rid="embj201694401-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="embj201694401-cr-0010" contrib-type="author">
          <name>
            <surname>Whitworth</surname>
            <given-names>Alexander J</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1154-6629</contrib-id>
          <xref ref-type="aff" rid="embj201694401-aff-0002">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="embj201694401-curr-0001">
<sup>4</sup>
</xref>
        </contrib>
        <contrib id="embj201694401-cr-0011" contrib-type="author">
          <name>
            <surname>Kaspar</surname>
            <given-names>Brian K</given-names>
          </name>
          <xref ref-type="aff" rid="embj201694401-aff-0003">
<sup>3</sup>
</xref>
        </contrib>
        <contrib id="embj201694401-cr-0012" contrib-type="author">
          <name>
            <surname>Meyer</surname>
            <given-names>Kathrin</given-names>
          </name>
          <xref ref-type="aff" rid="embj201694401-aff-0003">
<sup>3</sup>
</xref>
        </contrib>
        <contrib id="embj201694401-cr-0013" contrib-type="author">
          <name>
            <surname>Shaw</surname>
            <given-names>Pamela J</given-names>
          </name>
          <xref ref-type="aff" rid="embj201694401-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="embj201694401-cr-0014" contrib-type="author">
          <name>
            <surname>Grierson</surname>
            <given-names>Andrew J</given-names>
          </name>
          <xref ref-type="aff" rid="embj201694401-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="author-notes" rid="embj201694401-note-0002">
<sup>â¡</sup>
</xref>
        </contrib>
        <contrib id="embj201694401-cr-0015" contrib-type="author" corresp="yes">
          <name>
            <surname>De Vos</surname>
            <given-names>Kurt J</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2161-6309</contrib-id>
          <xref ref-type="aff" rid="embj201694401-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="author-notes" rid="embj201694401-note-0002">
<sup>â¡</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="embj201694401-aff-0001">
        <label>
          <sup>1</sup>
        </label>
        <named-content content-type="organisation-division">Sheffield Institute for Translational Neuroscience (SITraN)</named-content>
        <institution>Department of Neuroscience</institution>
        <institution>University of Sheffield</institution>
        <named-content content-type="city">Sheffield</named-content>
        <country country="GB">UK</country>
      </aff>
      <aff id="embj201694401-aff-0002">
        <label>
          <sup>2</sup>
        </label>
        <named-content content-type="organisation-division">Department of Biomedical Science</named-content>
        <institution>University of Sheffield</institution>
        <named-content content-type="city">Sheffield</named-content>
        <country country="GB">UK</country>
      </aff>
      <aff id="embj201694401-aff-0003">
        <label>
          <sup>3</sup>
        </label>
        <institution>The Research Institute at Nationwide Children's Hospital</institution>
        <named-content content-type="city">Columbus</named-content>
        <named-content content-type="country-part">OH</named-content>
        <country country="US">USA</country>
      </aff>
      <aff id="embj201694401-curr-0001"><label><sup>4</sup></label>Present address: <institution>MRC Mitochondrial Biology Unit</institution><named-content content-type="city">Cambridge</named-content><country country="GB">UK</country></aff>
      <author-notes>
        <corresp id="correspondenceTo"><label>*</label>Corresponding author. Tel: +44 114 222 2241; Eâmail: <email>k.de_vos@sheffield.ac.uk</email></corresp>
        <fn fn-type="equal" id="embj201694401-note-0001">
          <label>â </label>
          <p>These authors contributed equally to this work</p>
        </fn>
        <fn fn-type="equal" id="embj201694401-note-0002">
          <label>â¡</label>
          <p>These authors contributed equally to this work</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>22</day>
        <month>6</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <day>01</day>
        <month>8</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>22</day>
        <month>6</month>
        <year>2016</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
      <volume>35</volume>
      <issue>15</issue>
      <issue-id pub-id-type="doi">10.1002/embj.v35.15</issue-id>
      <fpage>1656</fpage>
      <lpage>1676</lpage>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>3</month>
          <year>2016</year>
        </date>
        <date date-type="rev-recd">
          <day>02</day>
          <month>6</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>03</day>
          <month>6</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2016 EMBO <copyright-statement>-->
        <copyright-statement content-type="article-copyright">Â© 2016 The Authors. Published under the terms of the CC BY 4.0 license</copyright-statement>
        <license license-type="creativeCommonsBy-nc-nd">
          <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:EMBJ-35-1656.pdf"/>
      <abstract id="embj201694401-abs-0001">
        <title>Abstract</title>
        <p>A <styled-content style="fixed-case">GGGGCC</styled-content> hexanucleotide repeat expansion in the <italic>C9orf72</italic> gene is the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia (C9<styled-content style="fixed-case">ALS</styled-content>/<styled-content style="fixed-case">FTD</styled-content>). <italic>C9orf72</italic> encodes two C9orf72 protein isoforms of unclear function. Reduced levels of C9orf72 expression have been reported in C9<styled-content style="fixed-case">ALS</styled-content>/<styled-content style="fixed-case">FTD</styled-content> patients, and although C9orf72 haploinsufficiency has been proposed to contribute to C9<styled-content style="fixed-case">ALS</styled-content>/<styled-content style="fixed-case">FTD</styled-content>, its significance is not yet clear. Here, we report that C9orf72 interacts with Rab1a and the Uncâ51âlike kinase 1 (<styled-content style="fixed-case">ULK</styled-content>1) autophagy initiation complex. As a Rab1a effector, C9orf72 controls initiation of autophagy by regulating the Rab1aâdependent trafficking of the <styled-content style="fixed-case">ULK</styled-content>1 autophagy initiation complex to the phagophore. Accordingly, reduction of C9orf72 expression in cell linesÂ and primary neurons attenuated autophagy and caused accumulation of p62âpositive puncta reminiscent of the p62 pathology observed in C9<styled-content style="fixed-case">ALS</styled-content>/<styled-content style="fixed-case">FTD</styled-content> patients. Finally, basal levels of autophagy were markedly reduced in C9<styled-content style="fixed-case">ALS</styled-content>/<styled-content style="fixed-case">FTD</styled-content> patientâderived <styled-content style="fixed-case">iN</styled-content>eurons. Thus, our data identify C9orf72 as a novel Rab1a effector in the regulation of autophagy and indicate that C9orf72 haploinsufficiency and associated reductions in autophagy might be the underlying cause of C9<styled-content style="fixed-case">ALS</styled-content>/<styled-content style="fixed-case">FTD</styled-content>âassociated p62 pathology.</p>
      </abstract>
      <kwd-group kwd-group-type="author-generated">
        <kwd id="embj201694401-kwd-0001">amyotrophic lateral sclerosis</kwd>
        <kwd id="embj201694401-kwd-0002">autophagy</kwd>
        <kwd id="embj201694401-kwd-0003">C9orf72</kwd>
        <kwd id="embj201694401-kwd-0004">frontotemporal dementia</kwd>
        <kwd id="embj201694401-kwd-0005">Rab <styled-content style="fixed-case">GTP</styled-content>ase</kwd>
      </kwd-group>
      <kwd-group kwd-group-type="subject-categories">
        <title>Subject Categories</title>
        <kwd>Neuroscience</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>Thierry Latran Foundation</funding-source>
          <award-id>RoCIP</award-id>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>Medical Research Council</funding-source>
          <award-id>MR/K005146/1</award-id>
          <award-id>MR/M013251/1</award-id>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>Alzheimer's Society</funding-source>
          <award-id>260 (ASâPGâ15â023)</award-id>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>University of Sheffield</funding-source>
          <award-id>Moody Family Endowment</award-id>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>European Union Seventh Framework Programme</funding-source>
          <award-id>EuroMOTOR 259867</award-id>
          <award-id>303101</award-id>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>Motor Neurone Disease Association</funding-source>
          <award-id>DeVos/Oct13/870â892</award-id>
        </award-group>
      </funding-group>
      <counts>
        <page-count count="21"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>source-schema-version-number</meta-name>
          <meta-value>2.0</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>component-id</meta-name>
          <meta-value>embj201694401</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>cover-date</meta-name>
          <meta-value>01 August 2016</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>details-of-publishers-convertor</meta-name>
          <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.4 mode:remove_FC converted:06.10.2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
    <notes>
      <p content-type="self-citation">
<mixed-citation publication-type="journal" id="embj201694401-cit-1001">
<source>The EMBO Journal</source> (<year>2016</year>) <volume>35</volume>: <fpage>1656</fpage>â<lpage>1676</lpage>
<pub-id pub-id-type="pmid">27334615</pub-id></mixed-citation>
</p>
    </notes>
  </front>
  <body>
    <sec id="embj201694401-sec-0001">
      <title>Introduction</title>
      <p>Macroautophagy (hereafter termed autophagy) is a conserved lysosomal degradation pathway that is an essential process to maintain cellular homeostasis. A double lipid membrane, the phagophore, engulfs cellular components targeted for degradation including proteins and organelles. The resulting autophagosome fuses with lysosomes, and its content is degraded to release cell components that can be reused. Autophagy is induced in response to starvation to boost nutrient availability, but is also responsible for the removal of defunct, damaged organelles and misfolded/aggregated proteins. Defects in autophagy are linked with several human diseases, including neurological disorders such as Parkinson's disease and amyotrophic lateral sclerosis (ALS) (Harris &amp; Rubinsztein, <xref rid="embj201694401-bib-0028" ref-type="ref">2012</xref>).</p>
      <p>A GGGGCC hexanucleotide repeat expansion in intron 1 of the <italic>C9orf72</italic> gene was found to be a common cause of both ALS and frontotemporal dementia (FTD) (DeJesusâHernandez <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0015" ref-type="ref">2011</xref>; Renton <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0052" ref-type="ref">2011</xref>), accounting for approximately 40 and 25% of familial ALS and FTD, respectively, and approximately 6% of sporadic ALS (Majounie <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0041" ref-type="ref">2012</xref>). C9ALS/FTD cases are distinguished from other ALS and FTD cases by specific ubiquitin and p62âpositive but TDPâ43ânegative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus (AlâSarraj <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0003" ref-type="ref">2011</xref>; CooperâKnock <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0011" ref-type="ref">2012</xref>; Mackenzie <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0040" ref-type="ref">2014</xref>).</p>
      <p>Reduced levels of <italic>C9orf72</italic> mRNA have been reported in postâmortem tissue, patientâderived lymphoblast cell lines and iPSNs and in blood samples (DeJesusâHernandez <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0015" ref-type="ref">2011</xref>; CooperâKnock <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0011" ref-type="ref">2012</xref>; Gijselinck <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0024" ref-type="ref">2012</xref>, <xref rid="embj201694401-bib-0025" ref-type="ref">2015</xref>; Belzil <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0008" ref-type="ref">2013</xref>; Ciura <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0010" ref-type="ref">2013</xref>; Donnelly <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0016" ref-type="ref">2013</xref>; Mori <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0046" ref-type="ref">2013b</xref>; Xi <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0068" ref-type="ref">2013</xref>) and reduced C9orf72 protein levels were detected in the frontal cortex of ALS and FTD cases (Waite <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0065" ref-type="ref">2014</xref>; Xiao <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0069" ref-type="ref">2015</xref>), suggesting haploinsufficiency may contribute to C9ALS/FTD by a lossâofâfunction mechanism. In addition, the pathogenic mechanism may involve a toxic gain of function via RNA toxicity (DeJesusâHernandez <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0015" ref-type="ref">2011</xref>; Donnelly <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0016" ref-type="ref">2013</xref>; LagierâTourenne <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0035" ref-type="ref">2013</xref>; Mizielinska <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0043" ref-type="ref">2013</xref>; Mori <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0046" ref-type="ref">2013b</xref>; Sareen <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0053" ref-type="ref">2013</xref>; Zu <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0071" ref-type="ref">2013</xref>) and/or repeatâassociated nonâATG (RAN) translation of the repeats into aggregationâprone dipeptideârepeat (DPR) proteins (Ash <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0005" ref-type="ref">2013</xref>; Gendron <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0023" ref-type="ref">2013</xref>; Mori <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0045" ref-type="ref">2013a</xref>,<xref rid="embj201694401-bib-0046" ref-type="ref">b</xref>; Zu <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0071" ref-type="ref">2013</xref>; Mizielinska <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0044" ref-type="ref">2014</xref>). Possibly all three mechanisms contribute to the pathogenesis of C9ALS/FTD in a multipleâhit fashion.</p>
      <p>Alternative splicing of <italic>C9orf72</italic> is predicted to yield three mRNAs that code for two C9orf72 isoforms, a 481 amino acid (aa) isoform of approximately 50Â kDa, C9orf72L (aa 1â481) and a 222 aa, 25Â kDa isoform, C9orf72S (aa 1â221), respectively (DeJesusâHernandez <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0015" ref-type="ref">2011</xref>). Data from <italic>C9orf72</italic> knockout mice have shown that C9orf72 is required for macrophage and microglial function <italic>inÂ vivo</italic> (Atanasio <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0006" ref-type="ref">2016</xref>; O'Rourke <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0049" ref-type="ref">2016</xref>; SudriaâLopez <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0059" ref-type="ref">2016</xref>; Sullivan <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0060" ref-type="ref">2016</xref>), but the neuronal function of C9orf72 remains unclear. It has been suggested that C9orf72 regulates endosomal/lysosomal trafficking via Rab GTPases, but details are lacking (Farg <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0021" ref-type="ref">2014</xref>). Alternatively, C9orf72 may be involved in nucleocytoplasmic shuttling (Xiao <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0069" ref-type="ref">2015</xref>). Bioinformatics analysis revealed that C9orf72 shows structural homology to the Differentially Expressed in Normal and Neoplasia (DENN) family of proteins which function as GDP/GTP exchange factors (GEF) of Rab GTPases (Zhang <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0070" ref-type="ref">2012</xref>; Levine <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0036" ref-type="ref">2013</xref>).</p>
      <p>Here, we show that C9orf72 is a Rab1a effector that controls initiation of autophagy by regulating the Rab1aâdependent trafficking of the ULK1 autophagy initiation complex to the phagophore. Disruption of C9orf72 function in cell lines and primary neurons inhibited autophagy and caused p62 accumulation similar to the specific pathology observed in C9ALS/FTD patients. Furthermore, basal autophagy levels were reduced in C9ALS/FTD patientâderived iNeurons. Together, these findings identify a novel function of C9orf72 and suggest a possible role for autophagy deficits by C9orf72 haploinsufficiency in C9ALS/FTD.</p>
    </sec>
    <sec id="embj201694401-sec-0002">
      <title>Results</title>
      <sec id="embj201694401-sec-0003">
        <title>C9orf72 regulates the initiation of autophagy</title>
        <p>C9ALS/FTD patients show specific ubiquitin and p62âpositive but TDPâ43ânegative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus, which is indicative of impaired autophagy (AlâSarraj <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0003" ref-type="ref">2011</xref>; CooperâKnock <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0011" ref-type="ref">2012</xref>; Mackenzie <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0040" ref-type="ref">2014</xref>). Because C9orf72 haploinsufficiency may contribute to C9ALS/FTD by a lossâofâfunction mechanism, we hypothesized that C9orf72 may be involved in autophagy.</p>
        <p>To test this directly, we reduced the expression of both C9orf72 isoforms in HeLa or HEK293 cells using a pool of two siRNAs directed against different regions of C9orf72, and in rat primary cortical neurons using miRNA and determined the effect of C9orf72 depletion on autophagy by monitoring microtubuleâassociated protein 1A/1B light chain 3 (LC3) flux (Spira <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0057" ref-type="ref">1993</xref>). During autophagy, the cytosolic form of LC3 (LC3âI) is lipidated to form LC3âII, which is recruited to autophagosomal membranes. LC3âII remains membrane associated throughout autophagy, and in the process, it is degraded in autolysosomes. Thus, turnover of LC3âII reflects the progression of autophagy. Due to questionable specificity of commercial C9orf72 antibodies, we used mRNA levels and RTâqPCR to confirm C9orf72 knockdown throughout this study (<xref rid="embj201694401-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S2</xref>). In mammalian cells, ULK1 controls the initial stages of autophagosome formation and is itself regulated in response to nutrient starvation by mammalian target of rapamycin (mTOR) kinase. Therefore, inhibitors of mTOR such as rapamycin and Torin1 are reliable experimental inducers of ULK1âdependent autophagy (Thoreen <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0063" ref-type="ref">2009</xref>).</p>
        <p>HeLa cells treated with nonâtargeting control siRNA or C9orf72 siRNA were transfected with mCherryâEGFPâLC3, and autophagy was induced using Torin1. We quantified the number of autophagosomes and autolysosomes by counting mCherryâEGFPâLC3âpositive puncta by fluorescence microscopy. mCherryâEGFPâLC3 allows distinction between autophagosomes and autolysosomes because EGFP fluorescence is quenched by the low pH in autolysosomes whereas mCherry fluorescence is not affected. Thus, autophagosomes fluoresce both red and green, whereas autolysosomes appear only red (Kimura <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0032" ref-type="ref">2007</xref>; Pankiv <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0050" ref-type="ref">2007</xref>). As expected, Torin1 treatment caused a large increase in autophagosomes and a more modest increase in autolysosomes in control siRNAâtreated cells. By contrast, in C9orf72 siRNAâtreated cells no increase in autophagosomes was observed after Torin1 treatment, and the increase in autolysosomes was significantly reduced (FigÂ <xref rid="embj201694401-fig-0001" ref-type="fig">1</xref>A). Thus, C9orf72 siRNA appeared to interfere with the induction of autophagy but not the later stages. To directly investigate this possibility, we treated HeLa cells with bafilomycin A1, a VâATPase inhibitor that causes an increase in lysosomal pH and blocks fusion of autophagosomes with lysosomes (Spira <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0057" ref-type="ref">1993</xref>). Under these conditions, counting autophagosomes allows specific quantification of the induction of autophagy (Tanida <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0062" ref-type="ref">2005</xref>). In control siRNAâtreated HeLa cells incubated with bafilomycin A1, Torin1 treatment induced autophagy and caused an increase in autophagosomes proportional to the level of induction. Conversely, in C9orf72 siRNAâtreated HeLa cells no increase was detected (FigÂ <xref rid="embj201694401-fig-0001" ref-type="fig">1</xref>B), indicating that loss of C9orf72 prevents induction of autophagy.</p>
        <fig fig-type="Figure" xml:lang="en" id="embj201694401-fig-0001" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <title>C9orf72 regulates the initiation of autophagy</title>
            <p>
<list list-type="simple" id="embj201694401-list-0002"><list-item><label>A, B</label><p>HeLa cells treated with nonâtargeting siRNA (Ctrl) or C9orf72 siRNA and transfected with mCherryâEGFPâLC3 were treated with vehicle (Ctrl), Torin1 (250Â nM; 3Â h), bafilomycin A1 (BafA1, 100Â nM; 6Â h), or combinations thereof as indicated. Autophagosomes (green+red) and autolysosomes (red only) were quantified per cell (meanÂ Â±Â SEM from 3 independent experiments; oneâway ANOVA with Fisher's LSD test: ns, not significant, *<italic>P</italic>Â â¤Â 0.05, **<italic>P</italic>Â â¤Â 0.01, ***<italic>P</italic>Â â¤Â 0.001, ****<italic>P</italic>Â â¤Â 0.0001; <italic>N</italic> (cells)Â =Â Ctrl/Ctrl: 120; Ctrl/Torin1: 101; C9orf72/Ctrl: 99; C9orf72/Torin1: 106; Ctrl/BafA1: 116; Ctrl/Torin1/BafA1: 118; C9orf72/BafA1: 109; C9orf72/Torin1/BafA1: 106). Scale barÂ =Â 20Â Î¼m. C9orf72 knockdown was confirmed by RTâqPCR (<xref rid="embj201694401-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S2</xref>).</p></list-item><list-item><label>C, D</label><p>HEK293 cells treated with nonâtargeting (Ctrl) or C9orf72 siRNA were incubated with BafA1, BafA1Â +Â Torin1 (C), or BafA1Â +Â rapamycin (D), and levels of LC3âI and II were determined by immunoblots. Levels of LC3âII were normalized against Î±âtubulin and are shown relative to the BafA1âtreated sample (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test: ns, not significant, *<italic>P</italic>Â â¤Â 0.05, **<italic>P</italic>Â â¤Â 0.01, ***<italic>P</italic>Â â¤Â 0.001, ****<italic>P</italic>Â â¤Â 0.0001; <italic>N</italic>Â =Â 3 experiments).</p></list-item><list-item><label>E, F</label><p>Primary cortical neurons (DIV5/6) were transfected with ECFP nonâtargeting (Ctrl) or C9orf72 miRNA (cyan) and EGFPâLC3 (green). Three days postâtransfection, neurons were treated with vehicle (Ctrl), Torin1 (250Â nM; 3Â h), BafA1 (100Â nM; 5Â h), or combinations thereof as indicated. Autophagosomes were quantified as the number of EGFPâLC3âpositive puncta per soma from 2 independent experiments (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test: ns, not significant, *<italic>P</italic>Â â¤Â 0.05; ***<italic>P</italic>Â â¤Â 0.001; ****<italic>P</italic>Â â¤Â 0.0001; <italic>N</italic> (cells)Â =Â Ctrl miRNA/Ctrl: 77; Ctrl miRNA/Torin1: 68; C9orf72 miRNA/Ctrl: 57; C9orf72 miRNA/Torin1: 69; Ctrl miRNA/BafA1: 35; Ctrl miRNA/Torin1/BafA1: 57; C9orf72 miRNA/BafA1: 66; C9orf72 miRNA/Torin1/BafA1: 64). Scale barÂ =Â 5Â Î¼m.</p></list-item></list>
</p>
            <p>
<named-content content-type="attribution">Source data are available online for this figure.</named-content>
</p>
          </caption>
          <graphic id="nlm-graphic-5" xlink:href="EMBJ-35-1656-g002"/>
        </fig>
        <p>In a complementary approach, we quantified the levels of endogenous LC3âII on immunoblots. In HEK293 cells treated with nonâtargeting control siRNA, inhibition of mTOR with either Torin1 (FigsÂ <xref rid="embj201694401-fig-0001" ref-type="fig">1</xref>C and <xref rid="embj201694401-fig-0001ev" ref-type="fig">EV1</xref>A) or rapamycin (FigsÂ <xref rid="embj201694401-fig-0001" ref-type="fig">1</xref>D and <xref rid="embj201694401-fig-0001ev" ref-type="fig">EV1</xref>B) in the presence of bafilomycin A1 caused a marked increase in LC3âII levels compared to control cells. However, consistent with inhibition of autophagy initiation, LC3âII levels did not increase upon induction of autophagy in HEK293 cells treated with C9orf72 siRNA (FigÂ <xref rid="embj201694401-fig-0001" ref-type="fig">1</xref>C and D), confirming the results obtained with mCherryâEGFPâLC3 in HeLa cells. To confirm the specificity of the siRNAs, we also tested the single siRNAs separately in this assay and found that both siRNAs knocked down C9orf72 and inhibited initiation of autophagy (<xref rid="embj201694401-sup-0001" ref-type="supplementary-material">AppendixÂ FigÂ S1</xref>).</p>
        <fig fig-type="Figure" xml:lang="en" specific-use="collapsible" id="embj201694401-fig-0001ev" orientation="portrait" position="float">
          <label>Figure EV1</label>
          <caption>
            <title>C9orf72 regulates the initiation of autophagy</title>
            <p>
<list list-type="alpha-upper" id="embj201694401-list-0011"><list-item><p>HEK293 cells treated with nonâtargeting (Ctrl) or C9orf72 siRNA were incubated with vehicle (Ctrl), Torin1, BafA1, or BafA1Â +Â Torin1 for 3Â h, and levels of LC3âI and II were determined on immunoblots. Levels of LC3âII were normalized against Î±âtubulin and are shown relative to the BafA1âtreated sample (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test: ns, not significant; *<italic>P</italic>Â â¤Â 0.05, ****<italic>P</italic>Â â¤Â 0.0001; <italic>N</italic>Â =Â 3 experiments). These data are also shown in FigÂ <xref rid="embj201694401-fig-0001" ref-type="fig">1</xref>C.</p></list-item><list-item><p>HEK293 cells treated with nonâtargeting (Ctrl) or C9orf72 siRNA were incubated with vehicle (Ctrl), rapamycin, BafA1, or BafA1Â +Â rapamycin for 6Â h, and levels of LC3âI and II were determined on immunoblots. Levels of LC3âII were normalized against Î±âtubulin and are shown relative to the BafA1âtreated sample (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test: ns, not significant; **<italic>P</italic>Â â¤Â 0.01, ***<italic>P</italic>Â â¤Â 0.001; <italic>N</italic>Â =Â 3 experiments). These data are also shown in Fig <xref rid="embj201694401-fig-0001" ref-type="fig">1</xref>D.</p></list-item></list>
</p>
          </caption>
          <graphic id="nlm-graphic-7" xlink:href="EMBJ-35-1656-g003"/>
        </fig>
        <p>To assess whether loss of C9orf72 also affected induction of autophagy in neurons, we coâtransfected primary rat cortical neurons with EGFPâLC3 and nonâtargeting control miRNA or C9orf72 targeting miRNA and quantified the number of EGFPâLC3âpositive autophagosomes after treatment with Torin1 and/or bafilomycin A1. Compared to nonâtreated controls, Torin1 treatment caused an increase in autophagosomes in control miRNAâtransfected neurons but not in C9orf72 miRNAâtransfected neurons (FigÂ <xref rid="embj201694401-fig-0001" ref-type="fig">1</xref>E). Similarly, in control miRNA expressing neurons incubated with bafilomycin A1, Torin1 treatment induced autophagy and caused an increase in autophagosomes, but this was not the case in C9orf72 miRNAâtransfected neurons (FigÂ <xref rid="embj201694401-fig-0001" ref-type="fig">1</xref>F). Hence, loss of C9orf72 also prevents induction of autophagy in primary neurons.</p>
        <p>We next asked whether C9orf72 could induce autophagy and whether this involved the ULK1 initiation complex. FAK family kinaseâinteracting protein of 200Â kDa (FIP200) forms a stable complex with ULK1 and autophagyârelated 13 (ATG13) in the ULK1 initiation complex and is essential for the initiation of autophagy. Hence, FIP200 siRNA can be used to disrupt the ULK1 initiation complex (Hara <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0027" ref-type="ref">2008</xref>). We overexpressed C9orf72 in cells treated with nonâtargeting or FIP200 siRNA and monitored induction of autophagy by determining coâtransfected EGFPâLC3 conversion on immunoblots and by investigating the distribution of EGFPâLC3. InÂ control siRNAâtreated cells, overexpression of either C9orf72S or C9orf72L increased EGFPâLC3âII levels (FigÂ <xref rid="embj201694401-fig-0002" ref-type="fig">2</xref>A) and correspondingly the number of EGFPâLC3âpositive autophagosomes increased (FigÂ <xref rid="embj201694401-fig-0002" ref-type="fig">2</xref>B). Loss of FIP200 completely prevented induction of autophagy by expression of C9orf72 in both assays (FigsÂ <xref rid="embj201694401-fig-0002" ref-type="fig">2</xref>A and B). As expected, FIP200 siRNA also completely prevented induction of autophagy by Torin1 treatment (FigÂ <xref rid="embj201694401-fig-0002" ref-type="fig">2</xref>B). Thus, C9orf72 overexpression induces autophagy via the ULK1 complex.</p>
        <fig fig-type="Figure" xml:lang="en" id="embj201694401-fig-0002" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <title>C9orf72 induces autophagy via the <styled-content style="fixed-case">ULK</styled-content>1 complex</title>
            <p>
<list list-type="alpha-upper" id="embj201694401-list-0003"><list-item><p>HEK293 cells treated with nonâtargeting (Ctrl) or FIP200 siRNA were coâtransfected with EGFPâLC3 and either empty vector control (EV), MycâC9orf72S, or MycâC9orf72L. 24Â h postâtransfection cells were treated with vehicle or 100Â nM BafA1 for 6Â h. Samples were lysed and subjected to SDSâPAGE and immunoblot. Autophagy levels were determined by immunoblot for EGFPâLC3âI and II. Expression of MycâC9orf72 was confirmed using antiâMyc (* indicates a nonspecific band). FIP200 knockdown was confirmed using antiâFIP200 antibodies. Î±âtubulin was used as a loading control.</p></list-item><list-item><p>HeLa cells treated with nonâtargeting (Ctrl) or FIP200 siRNA were coâtransfected with empty vector (EV), MycâC9orf72S or MycâC9orf72L (red), and EGFPâLC3 (green) to label autophagosomes. As positive control, EVâtransfected cells were treated for 3Â h with Torin1 (250Â nM). Autophagy was quantified as the number of EGFPâLC3âpositive autophagosomes per cell from 3 independent experiments (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test: ****<italic>P</italic>Â â¤Â 0.0001, <italic>N</italic> (cells)Â =Â Ctrl/EV: 73; FIP200/EV: 76; Ctrl/EV/Torin1: 73, FIP200/EV/Torin1: 70; Ctrl/C9orf72L: 71; FIP200/C9orf72L: 74; Ctrl/C9orf72S: 72; FIP200/C9orf72S: 72). Scale barÂ =Â 20Â Î¼m. FIP200 knockdown was confirmed by immunoblot (<xref rid="embj201694401-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S2</xref>).</p></list-item></list>
</p>
            <p>
<named-content content-type="attribution">Source data are available online for this figure.</named-content>
</p>
          </caption>
          <graphic id="nlm-graphic-9" xlink:href="EMBJ-35-1656-g004"/>
        </fig>
        <p>Together, these results reveal that C9orf72 regulates autophagy initiation in cell lines and primary neurons via the ULK1 complex.</p>
      </sec>
      <sec id="embj201694401-sec-0004">
        <title>C9orf72 interacts with the ULK1 initiation complex</title>
        <p>To further characterize the involvement of C9orf72 in autophagy initiation, we investigated the interaction of C9orf72 with the ULK1 complex in coâimmunoprecipitation assays. In a first approach, HEK293 cells were transfected with Mycâ or FLAGâtagged C9orf72S or C9orf72L together with FLAGâFIP200, HAâULK1, or MycâATG13 and C9orf72 was isolated using antibodies against the Myc or FLAG tag. FLAGâFIP200, HAâULK1, and MycâATG13 specifically coâimmunoprecipitated with C9orf72S and C9orf72L in these assays (FigsÂ <xref rid="embj201694401-fig-0003" ref-type="fig">3</xref>AâC). Secondly, we immunoprecipitated transfected Mycâtagged C9orf72S or C9orf72L and probed the resulting immune pellet for endogenous FIP200, ULK1, and ATG13. All three endogenous members of the ULK1 initiation complex were detected in the C9orf72 immunoprecipitates (FigÂ <xref rid="embj201694401-fig-0003" ref-type="fig">3</xref>D and E).</p>
        <fig fig-type="Figure" xml:lang="en" id="embj201694401-fig-0003" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <title>C9orf72 interacts with the <styled-content style="fixed-case">ULK</styled-content>1 initiation complex</title>
            <p>
<list list-type="simple" id="embj201694401-list-0004"><list-item><label>AâC</label><p>Cell lysates of HEK293 cells coâtransfected with FLAGâFIP200 (A), or HAâULK1 (B) and either empty vector control, MycâC9orf72S, or MycâC9orf72L or with MycâATG13 (C) and either empty vector control, FLAGâC9orf72S, or FLAGâC9orf72L were subjected to immunoprecipitation with antiâMyc (A and B) or antiâFLAG (C) antibodies. Immune pellets were probed for MycâC9orf72 (A and B), FLAGâC9orf72 (C), FLAGâFIP200 (A), HAâULK1 (B), or MycâATG13 (C) on immunoblots.</p></list-item><list-item><label>D, E</label><p>Cell lysates of HEK293 cells transfected with empty vector control, MycâC9orf72S, or MycâC9orf72L were subjected to immunoprecipitation with antiâMyc antibodies. Immune pellets were probed for MycâC9orf72 and endogenous FIP200, ULK1, and ATG13. There are multiple alternatively spliced forms of ATG13 (Jung <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0030" ref-type="ref">2009</xref>; Alers <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0002" ref-type="ref">2011</xref>); ATG13* is most likely a smaller alternative spliced form of ATG13 that is enriched by interaction with C9orf72.</p></list-item><list-item><label>FâH</label><p>HeLa cells transfected with HAâULK1 or FlagâFIP200 and MycâC9orf72 or with MycâATG13 and EGFPâC9orf72 were fixed and processed for PLA analysis. Transfections were laced with mVenus to enable identification of transfected cells for analysis where required (green). PLA signals (red) were counted per cell (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test, ****<italic>P</italic>Â â¤Â 0.0001; <italic>N</italic> (cells)Â =Â (F) C9orf72S: 22; C9orf72L: 18; EV+FIP200: 18; C9orf72S+FIP200: 18; C9orf72L+FIP200: 17; (G) C9orf72S: 21; C9orf72L: 20; EV+ULK1: 20; C9orf72S+ULK1: 22; C9orf72L+ULK1: 20; (H) C9orf72S: 11; C9orf72L: 10; EV+ATG13: 11; C9orf72S+ATG13: 11; C9orf72L+ATG13: 11). Scale barÂ =Â 10Â Î¼m; see also FigÂ <xref rid="embj201694401-fig-0002ev" ref-type="fig">EV2</xref>.</p></list-item><list-item><label>IâK</label><p>
<sup>35</sup>Sâradiolabeled recombinant FIP200â6xHis segments (I), MycâATG13 (J), or HAâULK1 (K) were added to GST, GSTâC9orf72S, and GSTâC9orf72L immobilized on glutathioneâcoated beads. <sup>35</sup>Sâradiolabeled recombinant proteins were visualized by phosphorimager (top panels). Coomassieâstained GST, GSTâC9orf72S, and GSTâC9orf72L in the pullâdown samples are shown (bottom panels). The identity of the Coomassie protein bands was confirmed by mass spectrometry (<sup>#</sup> indicates <italic>E.Â coli</italic> DnaK chaperonin; * indicates <italic>E.Â coli</italic> 60kD chaperonin; <xref rid="embj201694401-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S3</xref>).</p></list-item></list>
</p>
            <p>
<named-content content-type="attribution">Source data are available online for this figure.</named-content>
</p>
          </caption>
          <graphic id="nlm-graphic-11" xlink:href="EMBJ-35-1656-g006"/>
        </fig>
        <p>We next investigated the interaction of C9orf72 with the ULK1 initiation complex <italic>inÂ situ</italic> by proximity ligation assay (PLA) (SÃ¶derberg <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0056" ref-type="ref">2006</xref>) in HeLa cells transfected with HAâULK1 or FLAGâFIP200 and MycâC9orf72 or with MycâATG13 and EGFPâC9orf72. Using antibodies against the tags, we observed proximity signals in all coâtransfected cells examined (FigsÂ <xref rid="embj201694401-fig-0003" ref-type="fig">3</xref>FâH and <xref rid="embj201694401-fig-0002ev" ref-type="fig">EV2</xref>), confirming the interaction of C9orf72 with the ULK1 initiation complex in intact cells. As negative controls, we transfected HeLa cells with only C9orf72, ULK1, FIP200, or ATG13 and found only very low numbers of proximity signals.</p>
        <fig fig-type="Figure" xml:lang="en" specific-use="collapsible" id="embj201694401-fig-0002ev" orientation="portrait" position="float">
          <label>Figure EV2</label>
          <caption>
            <title>C9orf72 interacts with the ULK1 initiation complex</title>
            <p>
<list list-type="alpha-upper" id="embj201694401-list-0012"><list-item><p>HeLa cells were transfected with FLAGâFIP200, MycâC9orf72S and MycâC9orf72L or coâtransfected with FLAGâFIP200 and either MycâC9orf72S or MycâC9orf72L as indicated. Transfections were laced with mVenus to enable identification of transfected cells for analysis (green). Transfected cells were probed with both antiâFLAG and antiâMyc antibodies and processed for PLA. PLA proximity signals per cell (red) were determined (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test: ****<italic>P</italic>Â â¤Â 0.0001; <italic>N</italic> (cells)Â =Â FLAGâFIP200: 18, MycâC9orf72S: 22, MycâC9orf72L: 18, FLAGâFIP200Â +Â MycâC9orf72S: 18, FLAGâFIP200Â +Â MycâC9orf72L: 17). Scale barÂ =Â 20Â Î¼m.</p></list-item><list-item><p>HeLa cells were transfected with HAâULK1, MycâC9orf72S and MycâC9orf72L or coâtransfected with HAâULK1 and either MycâC9orf72S or MycâC9orf72L as indicated. Transfections were laced with mVenus to enable identification of transfected cells for analysis (green). Transfected cells were probed with both antiâHA and antiâmyc antibodies and processed for PLA. PLA proximity signals per cell (red) were determined (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test: ****<italic>P</italic>Â â¤Â 0.0001; <italic>N</italic> (cells)Â =Â HAâULK1: 20, MycâC9orf72S: 21, MycâC9orf72L: 20, HAâULK1Â +Â MycâC9orf72S: 22, HAâULK1Â +Â MycâC9orf72L: 20). Scale barÂ =Â 20Â Î¼m.</p></list-item><list-item><p>HeLa cells were transfected with MycâATG13, EGFPâC9orf72S and EGFPâC9orf72L or coâtransfected with MycâATG13 and either EGFPâC9orf72S or EGFPâC9orf72L. The ATG13 transfection was laced with mVenus to enable detection of transfected cells for analysis (green). Transfected cells were probed with both antiâEGFP and antiâmyc antibodies and processed for PLA. PLA proximity signals per cell (red) were determined (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test: ****<italic>P</italic>Â â¤Â 0.0001; <italic>N</italic> (cells)Â =Â ATG13: 11, EGFPc2âC9orf72S: 11, EGFPc2âC9orf72L: 10, MycâATG13Â +Â EGFPc2âC9orf72S: 11, MycâATG13Â +Â EGFPc2âC9orf72L: 11). Scale barÂ =Â 20Â Î¼m.</p></list-item></list>
</p>
          </caption>
          <graphic id="nlm-graphic-13" xlink:href="EMBJ-35-1656-g005"/>
        </fig>
        <p>To further characterize the interaction of C9orf72 with the ULK1 complex, we tested for interactions in <italic>inÂ vitro</italic> binding assays. We incubated recombinant GSTâtagged C9orf72 with <italic>inÂ vitroâ</italic>translated <sup>35</sup>Sâradiolabeled FIP200â6xHis segments (aa 1â638, aa 639â1373, and aa 1374â1591), HAâULK1 or MycâATG13 and pulled down GSTâC9orf72 using glutathione beads. C9orf72S and C9orf72L bound toÂ the Nâterminus of FIP200 (aa 1â638) but not the middle segment aa 639â1373 (FigÂ <xref rid="embj201694401-fig-0003" ref-type="fig">3</xref>I). The Câterminus of FIP200 (aa 1374â1591) bound to C9orf72S and C9orf72L but also to the GST control, indicating that this was not a specific interaction (FigÂ <xref rid="embj201694401-fig-0003" ref-type="fig">3</xref>I). C9orf72S and C9orf72L also interacted with ATG13 and ULK1 (FigÂ <xref rid="embj201694401-fig-0003" ref-type="fig">3</xref>J and K).</p>
        <p>Together, these data show that C9orf72 interacts with the ULK1 initiation complex by binding to ULK1, ATG13, and the Nâterminus of FIP200.</p>
      </sec>
      <sec id="embj201694401-sec-0005">
        <title>Loss of C9orf72 does not affect ULK1 activation</title>
        <p>Under basal conditions, mTOR suppresses ULK1 activity by phosphorylating ULK1 at Ser757 (Kim <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0031" ref-type="ref">2011</xref>). Inactivated mTOR is released from the ULK1 complex and ULK1 Ser757 phosphorylation is lost, thereby enhancing ULK1 kinase activity, which in turn phosphorylates ATG13 and FIP200 to initiate autophagy (Ganley <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0022" ref-type="ref">2009</xref>; Jung <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0030" ref-type="ref">2009</xref>; Kim <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0031" ref-type="ref">2011</xref>). Thus, Ser757 phosphorylation of ULK1 is indicative of the activation state of the ULK1 complex. To investigate whether C9orf72 affected autophagy at the level of ULK1 activation, we monitored ULK1 Ser757 phosphorylation using phosphospecific antibodies. Inhibition of mTOR by rapamycin reduced phosphorylation of ULK1 on Ser757 in both control and C9orf72 siRNAâtreated HEK293 cells (FigÂ <xref rid="embj201694401-fig-0004" ref-type="fig">4</xref>A). Thus, loss of C9orf72 did not prevent activation of ULK1.</p>
        <fig fig-type="Figure" xml:lang="en" id="embj201694401-fig-0004" orientation="portrait" position="float">
          <label>Figure 4</label>
          <caption>
            <title>C9orf72 regulates translocation of the <styled-content style="fixed-case">ULK</styled-content>1 complex</title>
            <p>
<list list-type="alpha-upper" id="embj201694401-list-0005"><list-item><p>HEK293 cells were transfected with nonâtargeting (Ctrl) or C9orf72 siRNA. Cells were treated with rapamycin for 6Â h to induce autophagy. Activation of ULK1 was determined on immunoblots using phosphoâULK1 (Ser757), total ULK1, and GAPDH Abs (loading control).</p></list-item><list-item><p>HeLa cells treated with nonâtargeting (Ctrl) or C9orf72 siRNA were transfected with mCherryâFIP200. Twentyâfour hours postâtransfection, cells were treated for 3Â h with Torin1 (250Â nM) or vehicle (Ctrl). Translocation of the ULK1 complex was quantified as the number of mCherryâFIP200âpositive puncta per cell from 3 independent experiments (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test, ns: not significant, ****<italic>P</italic>Â â¤Â 0.0001; <italic>N</italic> (cells)Â =Â Ctrl/Ctrl: 65; Ctrl/Torin1: 60; C9orf72/Ctrl: 54; C9orf72/Torin1: 49). C9orf72 knockdown was determined by RTâqPCR (<xref rid="embj201694401-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S2</xref>). Scale barÂ =Â 10Â Î¼m.</p></list-item><list-item><p>Primary cortical neurons (DIV5/6) were transfected with EmGFP nonâtargeting (Ctrl) or C9orf72 miRNA (green) and mCherryâFIP200 (red); for rescue experiments, the cells were additionally transfected with mCeruleanâtagged C9orf72s and C9orf72L (cyan). Three days postâtransfection, neurons were treated for 3Â h with Torin1 (250Â nM) or vehicle (Ctrl). Translocation of the ULK1 complex was quantified as the number of mCherryâFIP200âpositive puncta per soma from 2 independent experiments (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test, ns: not significant, ***<italic>P</italic>Â â¤Â 0.001, ****<italic>P</italic>Â â¤Â 0.0001; <italic>N</italic> (cells)Â =Â Ctrl miRNA/Ctrl: 134; Ctrl miRNA/Torin1: 125; C9orf72 miRNA/Ctrl: 101; C9orf72 miRNA/Torin1: 78; C9orf72 miRNA+C9orf72L+C9orf72S: 41; C9orf72 miRNA+C9orf72L+C9orf72S/Torin1: 39). Scale barÂ =Â 5Â Î¼m.</p></list-item><list-item><p>HeLa cells were coâtransfected with mCherryâFIP200 (red) and empty vector (EV), FLAGâC9orf72L, or FLAGâC9orf72S (green). As positive control, EVâtransfected cells were treated for 3Â h with Torin1 (250Â nM). Translocation of the ULK1 complex was quantified as the number of mCherryâFIP200âpositive puncta per cell from 3 independent experiments (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test, ***<italic>P</italic>Â â¤Â 0.001, ****<italic>P</italic>Â â¤Â 0.0001; <italic>N</italic> (cells)Â =Â EV: 47, EV+Torin1: 31, C9orf72L: 46, C9orf72S: 45). Scale barÂ =Â 10Â Î¼m.</p></list-item></list>
</p>
            <p>
<named-content content-type="attribution">Source data are available online for this figure.</named-content>
</p>
          </caption>
          <graphic id="nlm-graphic-15" xlink:href="EMBJ-35-1656-g008"/>
        </fig>
      </sec>
      <sec id="embj201694401-sec-0006">
        <title>C9orf72 regulates translocation of the ULK1 complex to the phagophore via Rab1a</title>
        <p>The activated ULK1 complex translocates to the phagophore to initiate autophagosome formation (Hara <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0027" ref-type="ref">2008</xref>). To investigate whether C9orf72 was involved in the translocation of the ULK1 complex to the phagophore, we monitored the translocation of mCherryâFIP200 in HeLa cells and primary rat cortical neurons treated with siRNA or transfected with miRNA to knock down C9orf72 expression, respectively. Under basal conditions, mCherryâFIP200 was found diffusely in the cytoplasm with some bright puncta observable in both control and C9orf72 knockdown HeLa cells (FigÂ <xref rid="embj201694401-fig-0004" ref-type="fig">4</xref>B) and rat cortical neurons (FigÂ <xref rid="embj201694401-fig-0004" ref-type="fig">4</xref>C). When we induced autophagy with Torin1, the number of mCherryâFIP200 puncta increased significantly in control cells, consistent with translocation of the ULK1 complex to the phagophore. In contrast, in C9orf72 knockdown cells and neurons, no increase above basal level was observed after treatment with Torin1 (FigÂ <xref rid="embj201694401-fig-0004" ref-type="fig">4</xref>B and C). To further assert the specificity of this effect, we reintroduced C9orf72 into C9orf72 miRNAâtransfected rat cortical neurons by transfection with human C9orf72. In these neurons, Torin1 treatment increased the number of mCherryâFIP200 puncta, showing that human C9orf72 rescued the inhibition of ULK1 complex translocation (FigÂ <xref rid="embj201694401-fig-0004" ref-type="fig">4</xref>C). Interestingly, overexpression of human C9orf72 per se significantly increased the number of mCherryâFIP200 puncta, indicating that increasing C9orf72 levels drives translocation of the ULK1 complex in absence of autophagy activators (FigÂ <xref rid="embj201694401-fig-0004" ref-type="fig">4</xref>C). To test this further, we overexpressed C9orf72 in HeLa cells and monitored mCherryâFIP200 translocation. Overexpression of either C9orf72 isoform significantly increased the number of mCherryâFIP200 puncta to similar levels as found after Torin1 treatment (FigÂ <xref rid="embj201694401-fig-0004" ref-type="fig">4</xref>D). Thus, C9orf72 is required for translocation of the ULK1 complex in cell lines and primary neurons.</p>
        <p>In yeast, Ypt1 (the yeast homolog of Rab1) regulates translocation of Atg1 (ULK1 in mammals) to the phagophore (LynchâDay <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0039" ref-type="ref">2010</xref>; Wang <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0066" ref-type="ref">2013</xref>). To determine whether this was also the case in mammalian cells, we investigated mCherryâFIP200 translocation in HeLa cells and SHâSY5Y neuroblastoma cells in which we depleted Rab1a by siRNAâwe chose Rab1a because it had been shown to regulate autophagy in mammalian cells (Winslow <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0067" ref-type="ref">2010</xref>; Mukhopadhyay <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0047" ref-type="ref">2011</xref>) and because we had identified Rab1a as a potential binding partner of C9orf72 by yeast 2 hybrid (Y2H, Fig <xref rid="embj201694401-fig-0006" ref-type="fig">6</xref>A). Thus, our data suggested that C9orf72 might act with Rab1a to regulate translocation of the ULK1 complex and induce autophagy. To investigate this possibility, we quantified the induction of ULK1 complex translocation and autophagy elicited by increased C9orf72S or C9orf72L expression in Rab1a siRNAâtreated HeLa and SHâSY5Y neuroblastoma cells. Rab1a siRNA completely prevented translocation of mCherryâFIP200 induced by Torin1, confirming its role in ULK1 complex trafficking (FigÂ <xref rid="embj201694401-fig-0005" ref-type="fig">5</xref>A and B). Overexpression of C9orf72S or C9orf72L no longer induced translocation of mCherryâFIP200 in Rab1a siRNAâtreated cells, and the number of C9orf72âinduced EGFPâLC3âpositive autophagosomes was significantly reduced (FigÂ <xref rid="embj201694401-fig-0005" ref-type="fig">5</xref>AâC). In an alternative approach, we used dominant negative (DN) Rab1a to inhibit Rab1a in HeLa cells expressing MycâC9orf72S or C9orf72L and monitored mCherryâFIP200 and EGFPâLC3. Again inhibition of Rab1a function reduced mCherryâFIP200 translocation and autophagosome formation elicited by increased C9orf72S or C9orf72L expression (FigÂ <xref rid="embj201694401-fig-0003ev" ref-type="fig">EV3</xref>). Thus, C9orf72 regulates Rab1aâdependent trafficking of the ULK1 complex.</p>
        <fig fig-type="Figure" xml:lang="en" id="embj201694401-fig-0005" orientation="portrait" position="float">
          <label>Figure 5</label>
          <caption>
            <title>C9orf72 regulates translocation of the <styled-content style="fixed-case">ULK</styled-content>1 complex via Rab1a</title>
            <p>
<list list-type="simple" id="embj201694401-list-0006"><list-item><label>A, B</label><p>HeLa cells (A) or SHâSY5Y neuroblastoma cells (B) treated with nonâtargeting (Ctrl) or Rab1a siRNA were coâtransfected with mCherryâFIP200 (red) and empty vector (EV), MycâC9orf72L, or MycâC9orf72S (green). As positive control, EVâtransfected cells were treated for 3Â h with Torin1 (250Â nM). Translocation of the ULK1 complex was quantified as the number of mCherryâFIP200âpositive puncta per cell [A, HeLa, meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test; ns, not significant; ****<italic>P</italic>Â â¤Â 0.0001; <italic>N</italic> (cells from 3 independent experiments)Â =Â Ctrl/EV: 81; Ctrl/EV/Torin1: 48; Ctrl/C9orf72L: 86; Ctrl/C9orf72S: 48; Rab1a/EV: 79; Rab1a/EV/Torin1: 68; Rab1a/C9orf72L: 78; Rab1a/C9orf72S: 52; B, SHâSY5Y: meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test; ns, not significant; **<italic>P</italic>Â â¤Â 0.01; ****<italic>P</italic>Â â¤Â 0.0001; <italic>N</italic> (cells from 2 independent experiments)Â =Â Ctrl/EV: 70; Ctrl/EV/Torin1: 56; Ctrl/C9orf72L: 45; Ctrl/C9orf72S: 43; Rab1a/EV: 63; Rab1a/EV/Torin1: 55; Rab1a/C9orf72L: 44; Rab1a/C9orf72S: 37]. Rab1a knockdown was confirmed by RTâqPCR (<xref rid="embj201694401-sup-0001" ref-type="supplementary-material">AppendixÂ FigÂ S2</xref>). Scale barÂ =Â 10Â Î¼m.</p></list-item><list-item><label>C</label><p>SHâSY5Y neuroblastoma cells treated with nonâtargeting (Ctrl) or Rab1a siRNA were coâtransfected with EGFPâLC3 (green) and empty vector (EV), MycâC9orf72L, or MycâC9orf72S (red). As positive control, EVâtransfected cells were treated for 3Â h with Torin1 (250Â nM). Autophagosomes were quantified as the number of EGFPâLC3âpositive puncta per cell (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test; ns, not significant; *<italic>P</italic>Â â¤Â 0.05, ***<italic>P</italic>Â â¤Â 0.001, ****<italic>P</italic>Â â¤Â 0.0001; <italic>N</italic> (cells from 2 independent experiments)Â =Â Ctrl/EV: 102; Ctrl/EV/Torin1: 92; Ctrl/C9orf72L: 97; Ctrl/C9orf72S: 76; Rab1a/EV: 102; Rab1a/EV/Torin1: 107; Rab1a/C9orf72L: 101; Rab1a/C9orf72S: 87). Rab1a knockdown was confirmed by RTâqPCR (<xref rid="embj201694401-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S2</xref>). Scale barÂ =Â 10Â Î¼m.</p></list-item></list>
</p>
          </caption>
          <graphic id="nlm-graphic-17" xlink:href="EMBJ-35-1656-g009"/>
        </fig>
        <fig fig-type="Figure" xml:lang="en" specific-use="collapsible" id="embj201694401-fig-0003ev" orientation="portrait" position="float">
          <label>Figure EV3</label>
          <caption>
            <title>C9orf72 regulates translocation of the ULK1 complex to the phagophore via Rab1a</title>
            <p>
<list list-type="alpha-upper" id="embj201694401-list-0013"><list-item><p>HeLa cells were coâtransfected with empty vector (EV), FLAGâC9orf72S or FLAGâC9orf72S (green), MycâRab1aWT or dominant negative MycâRab1aS25N (DN), and mCherryâFIP200 (red). 24Â h postâtransfection, cells were treated with Torin1 (250Â nM; 3Â h). Translocation of the ULK1 complex was quantified as the number of mCherryâFIP200âpositive puncta per cell from 7 independent experiments (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test: ns, not significant, **<italic>P</italic>Â â¤Â 0.01, ****<italic>P</italic>Â â¤Â 0.0001; <italic>N</italic> (cells)Â =Â WT/EV: 142; WT/EV/Torin1: 73; WT/C9orf72L: 108; WT/C9orf72S: 123; DN/EV: 159; DN/EV/Torin1: 150; DN/C9orf72L: 159; DN/C9orf72S: 123). Scale barÂ =Â 10Â Î¼m.</p></list-item><list-item><p>HeLa cells were coâtransfected with empty vector (EV), FLAGâC9orf72S or FLAGâC9orf72S (red), MycâRab1aWT or dominant negative MycâRab1aS25N (DN), and EGFPâLC3 (green). 24Â h postâtransfection, cells were treated with Torin1 (250Â nM; 3Â h). Autophagosomes were quantified as the number of EGFPâLC3âpositive puncta per cell from 2 independent experiments (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test: ns, not significant, **<italic>P</italic>Â â¤Â 0.01, ****<italic>P</italic>Â â¤Â 0.0001; <italic>N</italic> (cells)Â =Â WT/EV: 51; WT/EV/Torin1: 53; WT/C9orf72L: 56; WT/C9orf72S: 41; DN/EV: 53; DN/EV/Torin1: 53; DN/C9orf72L: 55; DN/C9orf72S: 42). Scale barÂ =Â 10Â Î¼m.</p></list-item></list>
</p>
          </caption>
          <graphic id="nlm-graphic-19" xlink:href="EMBJ-35-1656-g007"/>
        </fig>
      </sec>
      <sec id="embj201694401-sec-0007">
        <title>C9orf72 interacts with Rab1a</title>
        <p>Our data and the structural homology of C9orf72 with DENN domain proteins that are GEFs for Rab GTPases (Zhang <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0070" ref-type="ref">2012</xref>; Levine <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0036" ref-type="ref">2013</xref>) suggested that C9orf72 might interact with Rab1a. Consistent with a direct interaction, we isolated a partial Rab1a clone (aa 46â205) in a Y2H screen of a human brain cDNA library with C9orf72S as âbaitâ (FigÂ <xref rid="embj201694401-fig-0006" ref-type="fig">6</xref>A). To test this interactionÂ further, we first transfected HEK293 cells with Mycâtagged Rab1a and FLAGâtagged C9orf72S or C9orf72L and performed coâimmunoprecipitation assays. Secondly, we immunoprecipitated transfected Mycâtagged C9orf72S or C9orf72L and probed the resulting immune pellet for endogenous Rab1a. In both assays, Rab1a coâimmunoprecipitated efficiently with C9orf72L and to a lesser extent with C9orf72S (FigÂ <xref rid="embj201694401-fig-0006" ref-type="fig">6</xref>B and C).</p>
        <fig fig-type="Figure" xml:lang="en" id="embj201694401-fig-0006" orientation="portrait" position="float">
          <label>Figure 6</label>
          <caption>
            <title>C9orf72 interacts with Rab1a</title>
            <p>
<list list-type="alpha-upper" id="embj201694401-list-0007"><list-item><p>A human brain random cDNA library was screened in a Y2H assay using C9orf72S as bait. A clone coding for aa 46â205 of Rab1a, comprising most of the GTPâbinding Gâbox domain and the Câterminal CCâmotif was found to interact with C9orf72S.</p></list-item><list-item><p>Cell lysates of HEK293 cells coâtransfected with MycâRab1a and either empty vector, FLAGâC9orf72S, or FLAGâC9orf72L were subjected to immunoprecipitation with antiâFLAG antibody. Bound protein was eluted from beads using excess FLAG peptide. Immune eluates were probed for FLAGâC9orf72 and MycâRab1a on immunoblots. The input levels of FLAGâC9orf72 and MycâRab1a in the transfected cells are shown (Inputs). * indicates remaining MycâRab1a signal after reprobing for FLAGâC9orf72.</p></list-item><list-item><p>Cell lysates of HEK293 cells transfected with MycâC9orf72S or MycâC9orf72L were subjected to immunoprecipitation with antiâMyc antibody. The resulting immune pellet was probed for endogenous Rab1a.</p></list-item><list-item><p>
<sup>35</sup>Sâradiolabeled recombinant MycâRab1a protein loaded with vehicle, GDP or GMPâPNP was added to GST, GSTâC9orf72S, and GSTâC9orf72L immobilized on glutathioneâcoated beads. <sup>35</sup>Sâradiolabeled recombinant MycâRab1a protein was visualized by phosphorimager (top panel). Coomassieâstained GST, GSTâC9orf72S, and GSTâC9orf72L in the pullâdown samples are shown (bottom panel). The identity of the Coomassie protein bands was confirmed by mass spectrometry (<sup>#</sup> indicates <italic>E.Â coli</italic> DnaK chaperonin; * indicates <italic>E.Â coli</italic> 60kD chaperonin; <xref rid="embj201694401-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S3</xref>). Relative binding of Rab1a to C9orf72 was quantified from 3 independent experiments (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test; ns, not significant; *<italic>P</italic>Â â¤Â 0.05; **<italic>P</italic>Â â¤Â 0.01; ***<italic>P</italic>Â â¤Â 0.001).</p></list-item><list-item><p>Increasing volumes of <sup>35</sup>Sâradiolabeled recombinant MycâC9orf72L protein were incubated with equal amounts of GSTâRab1a immobilized on glutathioneâcoated beads in an equilibrium binding experiment. 8Â Î¼l of <sup>35</sup>Sâradiolabeled recombinant MycâC9orf72L protein was incubated with GST as a negative control. Bound <sup>35</sup>Sâradiolabeled MycâC9orf72L protein was visualized by phosphorimager. Coomassieâstained GSTâRab1a and GST in the pullâdown samples are shown. Densitometry analysis of the amount of <sup>35</sup>Sâradiolabeled recombinant MycâC9orf72L protein bound to GSTâRab1a in the different binding reactions was used to fit an equilibrium binding hyperbola (<italic>R</italic>
<sup>2</sup> = 0.94).</p></list-item></list>
</p>
            <p>
<named-content content-type="attribution">Source data are available online for this figure.</named-content>
</p>
          </caption>
          <graphic id="nlm-graphic-21" xlink:href="EMBJ-35-1656-g010"/>
        </fig>
        <p>We next asked whether C9orf72 interacted with Rab1a in <italic>inÂ vitro</italic> binding assays. We incubated recombinant GSTâtagged C9orf72 with <italic>inÂ vitroâ</italic>translated <sup>35</sup>Sâradiolabeled Rab1a and pulled down GSTâC9orf72 using glutathione beads. Rab1a interacted with both C9orf72L and C9orf72S in these assays (FigÂ <xref rid="embj201694401-fig-0006" ref-type="fig">6</xref>D). Preloading Rab1a with GDP to mimic inactive Rab1a did not alter binding to C9orf72, but preloading Rab1a with the nonâhydrolysable GTP analog GMPâPNP to mimic activated Rab1a increased interaction of Rab1a with C9orf72S and C9orf72L twoâ and fourfold, respectively (FigÂ <xref rid="embj201694401-fig-0006" ref-type="fig">6</xref>D). To further validate the specificity of the C9orf72âRab1a interaction, we performed an equilibrium binding experiment using increasing concentrations of radiolabeled C9orf72 protein and a constant amount of GSTâRab1a. There was no binding to the GSTânegative pullâdown control and increased binding of C9orf72 to GSTâRab1a with increasing concentrations of C9orf72 protein added. Consistent with a specific interaction, the resulting binding curve fitted a hyperbola (<italic>R</italic>
<sup>2</sup>Â =Â 0.94) which is characteristic of a biological interaction (FigÂ <xref rid="embj201694401-fig-0006" ref-type="fig">6</xref>E; Pollard, <xref rid="embj201694401-bib-0051" ref-type="ref">2010</xref>). Thus, C9orf72 binds to Rab1a and behaves as a Rab1a effector rather than a Rab1aÂ GEF.</p>
      </sec>
      <sec id="embj201694401-sec-0008">
        <title>C9orf72 mediates interaction of Rab1a with the ULK1 complex</title>
        <p>We reasoned that C9orf72 may recruit activated Rab1a to the ULK1 complex to initiate translocation. To test this, we probed the interaction of HAâULK1 and MycâRab1a in HeLa cells treated with nonâtargeting control siRNA or C9orf72 siRNA by <italic>inÂ situ</italic> PLA. In control siRNAâtreated cells, we observed proximity signals in all cells coâtransfected with HAâULK1 and MycâRab1a while in cells transfected with HAâULK1 or MycâRab1a alone only very low numbers of proximity signals were observed. In contrast, in cells treated with C9orf72 siRNA proximity signals were no longer detected in HAâULK1 and MycâRab1aâcoâtransfected cells (FigÂ <xref rid="embj201694401-fig-0007" ref-type="fig">7</xref>A). Thus, these data show ULK1âRab1a interaction in intact cells and reveal that this interaction is C9orf72 dependent.</p>
        <fig fig-type="Figure" xml:lang="en" id="embj201694401-fig-0007" orientation="portrait" position="float">
          <label>Figure 7</label>
          <caption>
            <title>C9orf72 mediates interaction of Rab1a with the <styled-content style="fixed-case">ULK</styled-content>1 complex</title>
            <p>
<list list-type="alpha-upper" id="embj201694401-list-0008"><list-item><p>HEK293 cells treated with nonâtargeting (Ctrl) or C9orf72 siRNA were transfected with HAâULK1, MycâRab1a, or HAâULK1Â +Â MycâRab1a as indicated. Transfections were laced with mVenus to enable identification of transfected cells for analysis (green). Transfected cells were probed with antiâHA and antiâMyc antibodies and processed for PLA. PLA proximity signals (red) per cell were determined from 3 independent experiments (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test, ****<italic>P</italic>Â â¤Â 0.0001; <italic>N</italic> (cells)Â =Â Ctrl/HAâULK1: 125, Ctrl/MycâRab1a: 149, Ctrl/HAâULK1Â +Â MycâRab1a: 163, C9orf72/HAâULK1: 136, C9orf72/MycâRab1a: 133, C9orf72/HAâULK1Â +Â MycâRab1a: 155). Scale barÂ =Â 20Â Î¼m.</p></list-item><list-item><p>HeLa cells treated with nonâtargeting (Ctrl) or C9orf72 siRNA were coâtransfected with mCherryâFIP200 (red) and empty vector (EV) or MycâRab1a(Q70L) (green). Translocation of the ULK1 complex was quantified as the number of mCherryâFIP200âpositive puncta per cell from 4 independent experiments (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test, *<italic>P</italic>Â â¤Â 0.05, ****<italic>P</italic>Â â¤Â 0.0001; <italic>N</italic> (cells)Â =Â Ctrl/EV: 101; Ctrl/Q70L: 106; C9orf72/Q70L: 42). C9orf72 knockdown was determined by RTâqPCR (<xref rid="embj201694401-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S2</xref>). Scale barÂ =Â 10Â Î¼m.</p></list-item><list-item><p>HeLa cells treated with nonâtargeting (Ctrl) or C9orf72 siRNA were coâtransfected with EGFPâLC3 (green) and empty vector (EV) or MycâRab1a(Q70L) (red). Autophagosomes were quantified as the number of EGFPâLC3âpositive puncta per cell (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test, **<italic>P</italic>Â â¤Â 0.01, ****<italic>P</italic>Â â¤Â 0.0001; <italic>N</italic> (cells)Â =Â Ctrl/EV: 44; Ctrl/Q70L: 32; C9orf72/Q70L: 47). C9orf72 knockdown was determined by RTâqPCR (<xref rid="embj201694401-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S2</xref>). Scale barÂ =Â 10Â Î¼m.</p></list-item></list>
</p>
          </caption>
          <graphic id="nlm-graphic-23" xlink:href="EMBJ-35-1656-g011"/>
        </fig>
        <p>To test the functional significance of these interactions, we transfected HeLa cells that were treated with control or C9orf72 siRNA with dominant active Rab1a(Q70L) and monitored mCherryâFIP200 translocation and EGFPâLC3âpositive autophagosomes. Consistent with the Rab1a dependency of ULK1 complex translocation, in control siRNAâtreated cells Rab1a(Q70L) induced translocation of mCherryâFIP200 and Rab1a(Q70L) appeared punctate and coâlocalized with FIP200âpositive structures. In contrast, in C9orf72 siRNAâtreated cells Rab1a(Q70L) appeared more uniformly distributed in the cytoplasm and did not induce FIP200 translocation (FigÂ <xref rid="embj201694401-fig-0007" ref-type="fig">7</xref>B). Similarly, overexpression of Rab1a(Q70L) increased the number of autophagosomes in control siRNAâtreated cells but not in C9orf72 siRNAâtreated cells (FigÂ <xref rid="embj201694401-fig-0007" ref-type="fig">7</xref>C).</p>
        <p>In conclusion, these data are consistent with a model in which C9orf72 acts as an effector of Rab1a that recruits active Rab1a to the ULK1 complex to promote translocation of the ULK1 complex to the phagophore during autophagy initiation.</p>
      </sec>
      <sec id="embj201694401-sec-0009">
        <title>C9orf72 depletion induces p62 accumulation</title>
        <p>C9ALS/FTD appears to involve haploinsufficiency of C9orf72 (DeJesusâHernandez <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0015" ref-type="ref">2011</xref>; CooperâKnock <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0011" ref-type="ref">2012</xref>; Gijselinck <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0024" ref-type="ref">2012</xref>, <xref rid="embj201694401-bib-0025" ref-type="ref">2015</xref>; Belzil <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0008" ref-type="ref">2013</xref>; Ciura <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0010" ref-type="ref">2013</xref>; Donnelly <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0016" ref-type="ref">2013</xref>; Mori <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0046" ref-type="ref">2013b</xref>; Xi <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0068" ref-type="ref">2013</xref>; Waite <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0065" ref-type="ref">2014</xref>). Our data predict that C9orf72 haploinsufficiency would impair autophagy. In agreement with this, C9ALS/FTD patients show characteristic p62âpositive, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus (AlâSarraj <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0003" ref-type="ref">2011</xref>; CooperâKnock <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0011" ref-type="ref">2012</xref>; Mackenzie <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0040" ref-type="ref">2014</xref>). To further investigate whether loss of C9orf72 is sufficient to cause p62 alterations consistent with the pathology in patients, we monitored endogenous p62 by immunofluorescence in C9orf72 siRNAâtreated HeLa cells and in primary cortical neurons transduced with C9orf72 miRNA. p62âpositive puncta accumulated in both HeLa and primary neurons depleted of C9orf72 when compared to nonâtargeting control (FigÂ <xref rid="embj201694401-fig-0008" ref-type="fig">8</xref>A and B). This accumulation was directly caused by loss of C9orf72 because reintroducing C9orf72 by transduction with human C9orf72 reduced the number of p62 puncta back to control level in C9orf72 miRNA knockdown rat cortical neurons (FigÂ <xref rid="embj201694401-fig-0008" ref-type="fig">8</xref>B). Thus, loss of C9orf72 mimics C9ALS/FTD p62 pathology <italic>inÂ vitro</italic>.</p>
        <fig fig-type="Figure" xml:lang="en" id="embj201694401-fig-0008" orientation="portrait" position="float">
          <label>Figure 8</label>
          <caption>
            <title>Loss of C9orf72 induces p62 accumulation</title>
            <p>
<list list-type="alpha-upper" id="embj201694401-list-0009"><list-item><p>HeLa cells treated with nonâtargeting (Ctrl) or C9orf72 siRNA were immunostained for endogenous p62. Accumulation of p62 was quantified by counting p62âpositive puncta per cell from 3 independent experiments (meanÂ Â±Â SEM; unpaired <italic>t</italic>âtest, ****<italic>P</italic>Â â¤Â 0.0001; <italic>N</italic> (cells)Â =Â Ctrl: 74, C9orf72: 55). C9orf72 knockdown was confirmed by RTâqPCR (<xref rid="embj201694401-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S2</xref>). Scale barÂ =Â 10Â Î¼m.</p></list-item><list-item><p>Primary cortical neurons (DIV5) were transduced with 4TU/cell EmGFP nonâtargeting control miRNA (Ctrl) or C9orf72 miRNA (green); for rescue experiments, the cells were additionally transduced with 4TU/cell mVenusâtagged C9orf72s and C9orf72L (verified by immunoblot, <xref rid="embj201694401-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S2</xref>). Neurons were immunostained for endogenous p62 3Â days postâtransduction. Accumulation of p62 was quantified by counting p62âpositive puncta per soma from 2 independent experiments (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test, **<italic>P</italic>Â â¤Â 0.01; <italic>N</italic> (cells)Â =Â Ctrl miRNA: 80; C9orf72 miRNA: 80; C9orf72 miRNA+C9orf72L+C9orf72S: 75). Scale barÂ =Â 10Â Î¼m.</p></list-item></list>
</p>
          </caption>
          <graphic id="nlm-graphic-25" xlink:href="EMBJ-35-1656-g012"/>
        </fig>
      </sec>
      <sec id="embj201694401-sec-0010">
        <title>Basal levels of autophagy are reduced in C9ALS/FTD patientâderived iNeurons</title>
        <p>To further test the possible involvement of C9orf72 haploinsufficiency in C9ALS/FTD, we analyzed basal levels of autophagy in C9ALS/FTD patientâderived iNeurons. iNeurons were obtained by differentiation of iNPCs of two C9ALS/FTD patients and ageâ and genderâmatched controls (Meyer <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0042" ref-type="ref">2014</xref>) (<xref rid="embj201694401-sup-0001" ref-type="supplementary-material">AppendixÂ TableÂ S1</xref>). As iNPCs are not clonally expanded, they do not display clonal variability. We confirmed the levels of C9orf72 in these cells by RTâqPCR. Compared to the controls, all C9ALS/FTD cases showed a marked reduction in C9orf72, which is consistent with previous reports of haploinsufficiency in patient material (<xref rid="embj201694401-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S4</xref>). Both LC3âI and II were detectable in the controls and LC3âII accumulated upon treatment with bafilomycin A1 (FigsÂ <xref rid="embj201694401-fig-0009" ref-type="fig">9</xref>A and B). Untreated C9ALS/FTD cases displayed higher levels of LC3âI compared to their controls, but LC3âII levels were similar. Upon treatment with bafilomycin A1, LC3âII levels accumulated to detectable levels in the C9ALS/FTD cases, but the levels of LC3âII remained significantly below those found in bafilomycin A1âtreated controls. Thus, while autophagy was not completely blocked, there was a marked reduction of autophagy in C9ALS/FTD iNeurons compared to control iNeurons (FigÂ <xref rid="embj201694401-fig-0009" ref-type="fig">9</xref>A and B).</p>
        <fig fig-type="Figure" xml:lang="en" id="embj201694401-fig-0009" orientation="portrait" position="float">
          <label>Figure 9</label>
          <caption>
            <title>C9<styled-content style="fixed-case">ALS</styled-content>/<styled-content style="fixed-case">FTD iN</styled-content>eurons exhibit autophagy deficits</title>
            <p>
<list list-type="simple" id="embj201694401-list-0010"><list-item><label>A, B</label><p>Two C9ALS/FTD iNeuron cultures (201 in A and 183 in B) and their matching controls (209 in A and 155 in B) were treated with vehicle (Ctrl) or bafilomycin A1 (BafA1, 100Â nM; 6Â h) and processed for immunoblot detection of LC3. LC3âII levels were normalized to Î±âtubulin (meanÂ Â±Â SEM; oneâway ANOVA with Fisher's LSD test; ns, not significant; *<italic>P</italic>Â â¤Â 0.05; **<italic>P</italic>Â â¤Â 0.01; ****<italic>P</italic>Â â¤Â 0.0001; Ctrl 209/Pat 201, <italic>n</italic>Â =Â 4; Ctrl 155/Pat 183, <italic>n</italic>Â =Â 6).</p></list-item></list>
</p>
            <p>
<named-content content-type="attribution">Source data are available online for this figure.</named-content>
</p>
          </caption>
          <graphic id="nlm-graphic-27" xlink:href="EMBJ-35-1656-g013"/>
        </fig>
      </sec>
    </sec>
    <sec id="embj201694401-sec-0011">
      <title>Discussion</title>
      <p>We show that C9orf72 interacts with Rab1a and the ULK1 complex and mediates interaction of Rab1a with the ULK1 initiation complex to facilitate its trafficking to the phagophore and initiate autophagosome formation. Our data are in contrast to a previous report indicating an increase in LC3âII in C9orf72 siRNAâtreated SHâSY5Y cells which suggests a possible late autophagy defect (Farg <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0021" ref-type="ref">2014</xref>). Our experiments in HEK293, HeLa, and SHâSY5Y cells and in primary rat cortical neurons did not yield any evidence for involvement of C9orf72 in the late steps of autophagy. All our data firmly point toward a role of C9orf72 in autophagy initiation: (i) autophagic flux assays using multiple inducers and readouts in multiple cell lines and primary neurons show effects consistent with initiation defects in C9orf72 knockdown cells (FigÂ <xref rid="embj201694401-fig-0001" ref-type="fig">1</xref>), (ii) overexpression of C9orf72 induces autophagy in a FIP200âdependent way (FigÂ <xref rid="embj201694401-fig-0002" ref-type="fig">2</xref>), (iii) C9orf72 interacts with FIP200, ULK1, and ATG13 in the ULK1 initiation complex <italic>inÂ vitro</italic> and in cells (FigÂ <xref rid="embj201694401-fig-0003" ref-type="fig">3</xref>), (iv) C9orf72 interacts with Rab1a in Y2H, <italic>inÂ vitro</italic> and in cells to regulate translocation of the ULK1 complex which is known to be essential for autophagy initiation (FigsÂ <xref rid="embj201694401-fig-0004" ref-type="fig">4</xref>, <xref rid="embj201694401-fig-0005" ref-type="fig">5</xref>, <xref rid="embj201694401-fig-0006" ref-type="fig">6</xref>, <xref rid="embj201694401-fig-0007" ref-type="fig">7</xref>), and (v) our data in iNeurons give no indication for block in the later stages of autophagy (FigÂ <xref rid="embj201694401-fig-0009" ref-type="fig">9</xref>).</p>
      <p>
<italic>In silico</italic> sequence analysis revealed that C9orf72 shows structural homology to DENN family proteins which function as GEFs for Rab GTPases (Zhang <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0070" ref-type="ref">2012</xref>; Levine <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0036" ref-type="ref">2013</xref>). Recent work has shown that a complex comprising C9orf72, WDR41, and SMCR8 acts as a GEF for Rab8a and Rab39b in the autophagy pathway, thus providing functional evidence that C9orf72 is a <italic>bona fide</italic> DENN family protein with GEF activity (Sellier <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0054" ref-type="ref">2016</xref>). On the other hand, we show here that C9orf72 binds to Rab1a (FigÂ <xref rid="embj201694401-fig-0006" ref-type="fig">6</xref>) to regulate trafficking of the ULK1 complex during autophagy initiation (FigsÂ <xref rid="embj201694401-fig-0004" ref-type="fig">4</xref> and <xref rid="embj201694401-fig-0005" ref-type="fig">5</xref>). Moreover, we found that C9orf72 preferentially binds to GTPâloaded Rab1a, behavior expected of a Rab1a effector but not a Rab1a GEF (FigÂ <xref rid="embj201694401-fig-0006" ref-type="fig">6</xref>D). It is well established that Rab GTPases act in soâcalled Rab GEF/GAP cascades in which the transition from an upstream Rab to a downstream Rab is achieved by recruiting the GAP and GEF for the upstream and downstream Rab GTPases as effectors, respectively (Hutagalung &amp; Novick, <xref rid="embj201694401-bib-0029" ref-type="ref">2011</xref>; Ao <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0004" ref-type="ref">2014</xref>). Together, these data support the existence of a novel Rab GEF/GAP cascade, in which Rab1a as upstream Rab recruits C9orf72/SMCR8/WDR41 as a GEF of downstream Rab8a and Rab39b. As such, via interaction with the ULK1 complex, C9orf72 may link initiation of autophagy to downstream events. In agreement with such a model, SMCR8 and WDR41 were also found to associate with the ULK1 complex (Behrends <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0007" ref-type="ref">2010</xref>; Sullivan <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0060" ref-type="ref">2016</xref>).</p>
      <p>C9orf72 is the second Rab GTPase associated protein involved in ALS. Alsin (ALS2), associated with juvenile ALS, is a Rab5 GEF (Topp <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0064" ref-type="ref">2004</xref>). While Rab5 is best known for its vital role in the early endocytic pathway, similar to Rab1a, Rab5 also participates in autophagosome formation (Ao <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0004" ref-type="ref">2014</xref>). Whereas Rab1a regulates autophagosome formation via the Atg9/Atg2âAtg18 complex and as shown here regulates trafficking of the ULK1 initiation complex to the phagophore (FigsÂ <xref rid="embj201694401-fig-0004" ref-type="fig">4</xref> and <xref rid="embj201694401-fig-0005" ref-type="fig">5</xref>), Rab5 acts through the Vps34âAtg6/beclin1 class III PI3âkinase complex (Winslow <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0067" ref-type="ref">2010</xref>; Lipatova &amp; Segev, <xref rid="embj201694401-bib-0038" ref-type="ref">2012</xref>; Dou <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0017" ref-type="ref">2013</xref>; Wang <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0066" ref-type="ref">2013</xref>). Thus, both C9orf72 and Alsin appear to be regulators of trafficking events in the autophagy pathway.</p>
      <p>In the case of ALS2, disease is caused by loss of function of Alsin, suggesting defective autophagosome formation may be involved in ALS pathogenesis. Several groups have found that <italic>C9orf72</italic> mRNA levels are reduced in C9ALS/FTD (DeJesusâHernandez <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0015" ref-type="ref">2011</xref>; CooperâKnock <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0011" ref-type="ref">2012</xref>; Gijselinck <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0024" ref-type="ref">2012</xref>, <xref rid="embj201694401-bib-0025" ref-type="ref">2015</xref>; Belzil <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0008" ref-type="ref">2013</xref>; Ciura <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0010" ref-type="ref">2013</xref>; Donnelly <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0016" ref-type="ref">2013</xref>; Mori <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0046" ref-type="ref">2013b</xref>; Xi <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0068" ref-type="ref">2013</xref>) and reduced C9orf72 protein levels have been detected in the frontal cortex of ALS and FTD cases (Waite <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0065" ref-type="ref">2014</xref>; Xiao <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0069" ref-type="ref">2015</xref>). Moreover, it has been reported that C9orf72 repeat size correlates with transcriptional downregulation of the promoter and onset age of disease (Gijselinck <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0025" ref-type="ref">2015</xref>). Accordingly, C9orf72 loss of function by haploinsufficiency has been put forward as a possible cause of C9ALS/FTD, but this has been difficult to verify without knowing the cellular function of C9orf72. Here, we show that C9orf72 is required for the initiation of autophagy (FigÂ <xref rid="embj201694401-fig-0001" ref-type="fig">1</xref>) and that C9ALS/FTD patientâderived iNeurons have significantly impaired basal levels of autophagy (FigÂ <xref rid="embj201694401-fig-0009" ref-type="fig">9</xref>). Also in agreement with defective autophagy caused by C9orf72 loss of function, C9ALS/FTD patients show specific ubiquitin and p62âpositive inclusions in the brain (AlâSarraj <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0003" ref-type="ref">2011</xref>; CooperâKnock <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0011" ref-type="ref">2012</xref>; Mackenzie <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0040" ref-type="ref">2014</xref>) and our data show that loss of C9orf72 in cells and primary neurons mimics C9ALS/FTD p62 pathology (FigÂ <xref rid="embj201694401-fig-0008" ref-type="fig">8</xref>). Thus, our findings provide a molecular explanation for C9ALS/FTD p62 pathology and suggest that autophagy deficits due to C9orf72 haploinsufficiency may contribute to C9ALS/FTD. Clearly, more work is required to assess the contribution of defective autophagy to neuronal loss in C9ALS/FTD, but it is well established that loss of neuronal autophagy can cause neurodegeneration. Neuronâspecific knockout of the essential autophagy genes <italic>ATG7</italic>,<italic> ATG5,</italic> and <italic>RB1CC1</italic> (FIP200) in mice causes neurodegeneration, progressive deficits in motor function, including abnormal limbâclasping reflexes (as also observed in ALSâSOD1 mice) and a reduction in coordinated movement, that are accompanied by the accumulation of cytoplasmic inclusion bodies in neurons (Hara <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0026" ref-type="ref">2006</xref>; Komatsu <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0033" ref-type="ref">2006</xref>; Liang <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0037" ref-type="ref">2010</xref>). In these neuronal autophagyâdeficient mice, the cerebellum is particularly affected suggesting that the cerebellum is singularly reliant on autophagy (Hara <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0026" ref-type="ref">2006</xref>; Komatsu <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0033" ref-type="ref">2006</xref>; Liang <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0037" ref-type="ref">2010</xref>). Similarly, in C9ALS/FTD patients ubiquitin/p62âpositive/TDP43ânegative pathology appears to be largely restricted to the cerebellum and hippocampus (AlâSarraj <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0003" ref-type="ref">2011</xref>; CooperâKnock <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0011" ref-type="ref">2012</xref>; Mackenzie <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0040" ref-type="ref">2014</xref>). Knockout of <italic>C9orf72</italic> in mice did not cause motor neuron degeneration or motor deficits (Koppers <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0034" ref-type="ref">2015</xref>; Atanasio <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0006" ref-type="ref">2016</xref>; O'Rourke <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0049" ref-type="ref">2016</xref>; SudriaâLopez <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0059" ref-type="ref">2016</xref>; Sullivan <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0060" ref-type="ref">2016</xref>), indicating that in contrast to <italic>ATG7</italic>,<italic> ATG5,</italic> and <italic>RB1CC1</italic> (FIP200), <italic>C9orf72</italic> is not essential for all autophagy in mice. Alternatively, there may be redundancy of the <italic>C9orf72</italic> gene in mammalian species. Full knockout of <italic>C9orf72</italic> did cause altered immune responses in macrophages and microglia, suggesting C9orf72 regulates immune homeostasis (Atanasio <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0006" ref-type="ref">2016</xref>; O'Rourke <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0049" ref-type="ref">2016</xref>; SudriaâLopez <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0059" ref-type="ref">2016</xref>; Sullivan <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0060" ref-type="ref">2016</xref>). The role of autophagy in the immune system is well established (Shibutani <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0055" ref-type="ref">2015</xref>); thus, possibly C9orf72 plays a specific role in immuneârelated autophagy initiation. Consistent with defective autophagy, these <italic>C9orf72</italic> knockout mice showed lysosomal accumulation and increased amounts of p62 and both LC3âI and II in homozygote spleens (O'Rourke <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0049" ref-type="ref">2016</xref>; Sullivan <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0060" ref-type="ref">2016</xref>). However, since both LC3âI and II were increased, this is not likely to be due to a block in late autophagy as suggested by O'Rourke <italic>etÂ al</italic> (<xref rid="embj201694401-bib-0049" ref-type="ref">2016</xref>) but rather a compensatory increase in response to decreased autophagy initiation. Indeed, we observed a similar increase of LC3âI in patientâderived iNeurons (FigÂ <xref rid="embj201694401-fig-0009" ref-type="fig">9</xref>) and in <italic>C9orf72</italic> knockout zebrafish and mice (data not shown).</p>
      <p>Impaired autophagy has also been implicated in nonâC9orf72 ALS/FTD and other neurodegenerative diseases (Chen <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0009" ref-type="ref">2012</xref>; Harris &amp; Rubinsztein, <xref rid="embj201694401-bib-0028" ref-type="ref">2012</xref>). Abnormal autophagy has been found in SOD1 and TDP43 models of ALS, and as mentioned above, Alsin may regulate autophagy via Rab5. Furthermore, several ALS/FTD genes, such as charged multivesicular body proteinâ2B (CHMP2B), valosinâcontaining protein (VCP), ubiquilin 2, p62 (sequestosome 1), optineurin, and TANKâbinding kinase (TBK1), are directly linked to autophagy. Thus, neurodegeneration associated with defective neuronal autophagy appears to be intimately linked with ALS/FTD, reinforcing autophagy as a possible therapeutic target for ALS/FTD.</p>
    </sec>
    <sec id="embj201694401-sec-0012">
      <title>Materials and Methods</title>
      <sec id="embj201694401-sec-0013">
        <title>Plasmids</title>
        <p>C9orf72L and C9orf72S cDNA was generated by PCR using Phusion High Fidelity enzyme (NEB) from a HEK293 cDNA library prepared in house, using primers containing restriction sites. The Mycâ and FLAGâtagged constructs were cloned by standard subcloning techniques into pRK5âMyc and p3xFLAGâCMV, using SalI/NotI and HindIII/BamHI restriction sites, respectively. GSTâtagged C9orf72S and C9orf72L constructs were generated by subcloning into pGEX6p1 (GE Healthcare Life Sciences) using XhoI/NotI sites. EGFPâtagged C9orf72S and C9orf72L were generated by EcoRI/BamHI subcloning into pEGFPc2. mVenusâtagged C9orf72S and C9orf72L were generated by XhoI/NotI subcloning into pCIâNeoâmVenusâN, a modified pCIâneo vector containing mVenus cDNA, generated by PCR using Phusion High Fidelity enzyme from prSETBâmVenus (a gift from Atsushi Miyawaki, RIKEN, Japan). mVenusâC9orf72 was subcloned into pLvos, a modified pLâSINâPGKâcPPTâGDNFâWHV lentiviral vector (DÃ©glon <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0014" ref-type="ref">2000</xref>; Suzuki <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0061" ref-type="ref">2007</xref>) in which the original NheI and NotI sites were destroyed and the GDNF cDNA was replaced by a pCIâneoâderived multiple cloning site (5â²âgat cct aat acg act cac tat agg gcg gct agc ctc gag aat tca cgc gtc gcc ggc gca tat gct gca gcc cgg gcg gcc gct tcc ctt tag tga ggg tta atgâ3â²) using the NheI/NotI sites to yield pLvosâmVenusâC9orf72. pLâSINâPGKâcPPTâEGFPâWHV was a kind gift from M. Azzouz, SITraN, Sheffield UK (Nanou <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0048" ref-type="ref">2013</xref>). p3xFLAGâCMV10âhFIP200 was a gift from Noboru Mizushima, Tokyo Medical and Dental University, Japan, via Addgene (plasmid #24300) (Hara <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0027" ref-type="ref">2008</xref>). FIP200â6xHis fragments were generated by PCR using Phusion High Fidelity enzyme (primers: FIP200âFW: ctcgaggccaccâ<italic>atgaagttatatgtatttctggtta</italic> FIP200â638âR gcggccgctcaatggtggtggtgatgatgâ<italic>ttcactcagtagatctgtaatg</italic> FIP200â639âFW ctcgaggccaccatgâ<italic>caaaaggcatctgtgagtcag</italic> FIP200â1373â6HisâR gcggccgctcaatggtggtggtgatgatgâ<italic>ttcagaaagtgactctatcaaat</italic> FIP200â1374âFW ctcgaggccaccatgâ<italic>gatcgagctcgtttgcttgag</italic> FIP200â6HisâR gcggccgctcaatggtggtggtgatgatgâ<italic>ttatactttcttattccatgatacg</italic>) and transferred to pCiâNeo (Promega) using XhoI/NotI sites. mCherryâFIP200 was a gift from Xuejun Jiang, Memorial SloanâKettering Cancer Center, NYC, USA (Ganley <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0022" ref-type="ref">2009</xref>). pRK5âHAâULK1 and pRK5âMycâhATG13 were a gift from DoâHyung Kim, University of Minnesota, USA, via Addgene (plasmid #31963 and #31965) (Jung <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0030" ref-type="ref">2009</xref>). pCMVâintron MycâRab1aWT and MycâRab1aS25N were from T. HÃ©bert, McGill University, Canada, via Addgene (plasmid #46776 and #46777) (Dupre <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0019" ref-type="ref">2006</xref>). Rab1a(Q70L) was generated from Rab1aWT by siteâdirected mutagenesis using a QuikChange Lightning SiteâDirected Mutagenesis Kit (Agilent) according to the manufacturer's instructions using 5â²âtgttcgaaatctttccaggcctgctgtgtcccâ3â² and 5â²âgggacacagcaggcctggaaagatttcgaacaâ3â² primers. mCherryâEGFPâLC3b was a gift from Terje Johansen, University of TromsÃ¸, Norway (Pankiv <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0050" ref-type="ref">2007</xref>). EGFPâLC3b was a gift from Chris Miller, KCL, UK. All constructs were confirmed by sequencing.</p>
      </sec>
      <sec id="embj201694401-sec-0014">
        <title>Cell culture and transfection</title>
        <p>HEK293, HeLa, and SHâSY5Y cells (ATCC) were cultured in Dulbecco's modified Eagle's medium (DMEM, Sigma) supplemented with 10% FBS (Biosera) and 1Â mM sodium pyruvate (Sigma) in a 5% CO<sub>2</sub> atmosphere at 37Â°C. Cells were transfected with plasmid DNA using Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer's instructions or polyethylenimine (PEI) (stock 1Â mM; 3Â Î¼l/Î¼g plasmid). HeLa, HEK293, and SHâSY5Y cells were siRNA transfected using Lipofectamine RNAiMax or Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Cells were used for experiments 4Â days after siRNA transfection.</p>
        <p>Cortical neurons were isolated from E18 Sprague Dawley rat embryos (Charles River) and cultured on glass coverslips coated with polyâLâlysine in 12â or 24âwell plates in neurobasal medium supplemented with B27 supplement (Invitrogen), 100Â IU/ml penicillin, 100Â mg/ml streptomycin, and 2Â mM Lâglutamine. Cortical neurons (DIV5â6) were transfected using Lipofectamine LTX with PLUS reagent according to the manufacturer's instructions (Thermofisher). Briefly, neurons were placed in fresh culture medium with a DNA:PLUS:LTX ratio of 1:0.5:0.5 (0.5â1Â Î¼g DNA/100,000 cells/cm<sup>2</sup>). After 6Â h, the transfection mix was replaced with conditioned medium. For lentiviral transduction, neurons were exposed to 4TU/cell in fresh culture medium overnight.</p>
      </sec>
      <sec id="embj201694401-sec-0015">
        <title>iNPC production and neuronal differentiation</title>
        <p>Induced neural progenitor cells (iNPCs) were derived from human skin fibroblasts as previously described (Meyer <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0042" ref-type="ref">2014</xref>). Human skin fibroblast samples were obtained from PJS from the Sheffield tissue bank. Informed consent was obtained from all subjects before sample collection (Study number STH16573, Research Ethics Committee reference 12/YH/0330). Briefly, 10,000 fibroblasts were transduced with lentiviral vectors for OCT3, Sox2, KLF4, and CâMYC for 12Â h. Fortyâeight hours after transduction, the cells were washed with PBS and fibroblast medium was replaced with NPC medium (DMEM/Fâ12 with glutamax supplemented with 1% N2, 1% B27, 20Â ng/ml FGFâb, 20Â ng/ml EGF, and 5Â Î¼g/ml heparin. When the cells started changing shape and form neurospheres, they were expanded as neural rosettes. When the iNPC culture was confluent (~3Â weeks), EGF and heparin were withdrawn and the FGFâb concentration increased to 40Â ng/ml. The iNPCs can be maintained for ~30 passages. iNPCs are not expanded by clone and therefore do not display clonal variability.</p>
        <p>For differentiation, 30,000 iNPCs were plated in a 6âwell plate coated with fibronectin (Millipore) and expanded to 70â80% confluence after which iNPC medium was replaced with neuron differentiation medium (DMEM/Fâ12 with glutamax supplemented with 1% N2 and 2% B27). On day one of differentiation, the cells were treated with 2.5Â Î¼M DAPT (Tocris) to determine differentiation toward a neuronal lineage. On day three, the neuron differentiation medium was supplemented with 1Â Î¼M retinoic acid (Sigma), 0.5Â Î¼M smoothened agonist (SAG) (Millipore) and 2.5Â Î¼M forskolin (Sigma) for 7Â days. This protocol leads to typical yields of 70% Î²âIII tubulin (Tuj1)âpositive cells. iNeuron experiments were repeated at least 3 times for each sample starting from iNPCs at different passages, typically between passages 10 and 20 to ensure that the results observed are not determined by batch effects or passage number.</p>
      </sec>
      <sec id="embj201694401-sec-0016">
        <title>siRNA and miRNA</title>
        <p>Nonâtargeting control siRNA and targeting siRNA were purchased from Sigma. The siRNA sequences were as follows: C9orf72#2: gugcuauagauguaaaguu, C9orf72#D: gaucagggucagaguauua, FIP200#1 caaguuagagguugaacuu, FIP200#2 gaucuuaugugaucgucca, Rab1a#1 gaacaaucaccuccaguua, Rab1a#2 cagaucaggaguccuucaa.</p>
        <p>miRNA targeting rat C9orf72 (miR<sup>C9orf72</sup>) was designed using Invitrogen's RNAi Designer (<ext-link ext-link-type="uri" xlink:href="http://rnaidesigner.thermofisher.com/rnaiexpress/">http://rnaidesigner.thermofisher.com/rnaiexpress/</ext-link>) and cloned into the pcDNA6.2<sup>â¢</sup>âGW/EmGFP miR expression vector according to the manufacturer's instructions (BLOCKâiT<sup>â¢</sup> Pol II miR RNAi expression vector kit, Invitrogen; top strand: 5â²âtgc tgt atc cca gta agc aaa ggt agg ttt tgg cca ctg act gac cta cct ttt tac tgg gat aâ3â²). pcDNA6.2<sup>â¢</sup>âGW/ECFP miR was generated by replacing EmGFP with ECFP in pcDNA6.2<sup>â¢</sup>âGW/EmGFP. EmGFP miR<sup>C9orf72</sup> was amplified from pcDNA6.2<sup>â¢</sup>âGW using 5â²âgct agc aca agt ttg tac aaa aaa gcaâ3â² and 5â²âgcg gcc gcc aac cac ttt gta caa gaa agc tâ3â² primers and subcloned into pLvos using XhoI/NotI sites. Nonâtargeting miRNA is part of the BLOCKâiT<sup>â¢</sup> Pol II miR RNAi expression vector kit.</p>
      </sec>
      <sec id="embj201694401-sec-0017">
        <title>Lentiviral production</title>
        <p>3Â ÃÂ 10<sup>6</sup> HEK293T cells (ATCC) were seeded per 10âcm dish and transfected with 12.5Â Î¼g of DNA the following day (4.95Â Î¼g of pL expression constructs, 4.95Â Î¼g pCMVâdR8.92 (a gift from Bob Weinberg via Addgene (plasmid #8455)) (Stewart <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0058" ref-type="ref">2003</xref>), 1.45Â Î¼g pMD2.G, and 1.15Â Î¼g pRSVâRev (both from Didier Trono via Addgene (plasmid #12253 and #12259) (Dull <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0018" ref-type="ref">1998</xref>)) using polyethyleneimine (PEI, 1Â mg/ml; PolySciences) at a ratio of 1:3 (DNA:PEI). Cells were incubated for 72Â h, and virus particles were harvested by ultracentrifugation of the cell culture supernatants (90Â min at 65,000Â <italic>g</italic>, rotor SWâ28, Optima<sup>â¢</sup> Lâ100Â K Ultracentrifuge, Beckman Coulter). Viral pellets were resuspended in 1% BSA/PBS, and aliquots were stored at â80Â°C. In order to titer the viruses, HeLa cells were seeded into 12âwell plates at a density of 75,000 cells per well and transduced with 500Â Î¼l of a 10<sup>â2</sup>, 10<sup>â3</sup>, and 10<sup>â4</sup> dilution of the virus the next day. After 72Â h, cells were trypsinized and fixed (4% formaldehyde/PBS) and EGFP or mVenus fluorescence was analyzed by fluorescenceâactivated cell sorting (FACS; BD<sup>â¢</sup> LSR II Flow Cytometer). The following formula was used to calculate the number of TU/ml: number of cells before transduction/percentage of positive gated cellsÂ ÃÂ dilution factorÂ ÃÂ 2.</p>
      </sec>
      <sec id="embj201694401-sec-0018">
        <title>SDSâPAGE and immunoblotting</title>
        <p>Cells were harvested in trypsin/EDTA (Lonza) and pelleted at 400Â <italic>g</italic> for 4Â min. Pellets were washed once with phosphateâbuffered saline (PBS). Cells were lysed on ice for 30Â min in iceâcold RIPA buffer (50Â mM TrisâHCl pH 6.8, 150Â mM NaCl, 1Â mM EDTA, 1Â mM EGTA, 0.1% (w/v) SDS, 0.5% (w/v) deoxycholic acid, 1% (w/v) Triton Xâ100, and protease inhibitor cocktail (Thermo Scientific)). Lysates were clarified at 15,000Â <italic>g</italic> for 30Â min at 4Â°C. Protein concentration was measured by Bradford protein assay (BioâRad). Proteins were separated by SDSâPAGE and transferred to nitrocellulose membranes (Whatmann) by electroblotting (BioâRad). After transfer, membranes were blocked for 1Â h at room temperature in Trisâbuffered saline (TBS) with 5% fatâfree milk (Marvel) and 0.1% Tweenâ20. Membranes were incubated with primary antibodies in blocking buffer for 1Â h at room temperature or overnight at 4Â°C. Membranes were washed 3 times for 10Â min in TBS with 0.1% Tweenâ20 before incubation with secondary antibodies in block buffer for 1Â h at room temperature. After washing, membranes were prepared for chemiluminescent signal detection with SuperSignal West Pico Chemiluminescent substrate (Thermo Scientific) according to the manufacturer's instructions. Signals were detected with a SynGene Gbox or on ECL film (GE Healthcare). Signal intensities were quantified using ImageJ (Abramoff <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0001" ref-type="ref">2004</xref>).</p>
      </sec>
      <sec id="embj201694401-sec-0019">
        <title>Immunoprecipitation</title>
        <p>Cells were harvested in trypsin/EDTA and pelleted at 400Â <italic>g</italic> for 4Â min. Pellets were washed once with phosphateâbuffered saline (PBS). Cells were lysed at 4Â°C for 1Â h in iceâcold BRB80 lysis buffer (80Â mM KâPIPES pH 6.8, 1Â mM MgCl<sub>2</sub>, 1Â mM EDTA, 1% (w/v) NPâ40, and protease inhibitor cocktail). Lysates were clarified at 15,000Â <italic>g</italic> for 30Â min at 4Â°C. 2Â mg of protein was incubated with 2Â Î¼g of primary antibody for 16Â h at 4Â°C. Antibody was then captured by incubation with 25Â Î¼l of 50% protein GâSepharose (Sigma) for 2Â h at 4Â°C. After centrifuging at 3,000Â <italic>g</italic>, immune pellets were washed 5 times in iceâcold lysis buffer. Protein was eluted from protein G beads in 2ÃÂ Laemmli buffer. Samples were analyzed by SDSâPAGE and immunoblot.</p>
      </sec>
      <sec id="embj201694401-sec-0020">
        <title>
<italic>In vitro</italic> binding assays</title>
        <p>[<sup>35</sup>S]âmethionineâlabeled FIP200 fragments, HAâULK1, MycâATG13, and MycâRab1a were produced using the T7/SP6 TnT Quick Coupled Transcription/Translation kit (Promega). GST, GSTâC9orf72S, and GSTâC9orf72L were expressed from the pGEX6p1 vector in Rossetta PLysS cells. 0.1Â g GST cell pellet and 0.25Â g GSTâC9orf72 cell pellets were lysed by sonication in 1Â ml of buffer RB100 (25Â mM Hepes (pH 7.5), 100Â mM KOAc, 10Â mM MgCl<sub>2</sub>, 1Â mM DTT, 0.05% Triton Xâ100, 10% (vol/vol) glycerol), and GSTâtagged proteins bound to 30Â Î¼l of glutathioneâagarose (GSH) bead slurry. Binding reactions were carried out in 400Â Î¼l buffer RB100 containing the 30Â Î¼l GSH beads and bound proteins along with 8Â Î¼l of labeled protein. In case of MycâRab1a, 1Â mM GDP or 1Â mM GMPâPNP (guanosine 5â²â[Î²,Î³âimido]triphosphate trisodium salt hydrate) was added to the binding assays as indicated. Proteins were eluted from GSH beads using glutathione elution buffer (50Â mM TrisâHCl (pH 7.5), 100Â mM NaCl, 40Â mM reduced glutathione) and analyzed by SDSâPAGE. 1Â Î¼l reticulocyte lysate was loaded as input. Cells were stained with Coomassie to show GSTâtagged proteins and <sup>35</sup>S radiolabel was detected using a Typhoon Phosphorimager (GE Healthcare).</p>
      </sec>
      <sec id="embj201694401-sec-0021">
        <title>Antibodies</title>
        <p>Primary antibodies used were as follows: rabbit antiâhuman Tuj1 (Covance, IF: 1:500), mouse antiâFLAG (M2, Sigma, WB: 1:2,000, IF: 1:1,000), mouse antiâMyc (9B11, Cell Signaling, WB: 1:2,000, IF: 1:2,000), mouse antiâtubulin (DM1A, Sigma, WB: 1:10,000), rabbit antiâMyc (ab9106, Abcam, WB: 1:2,000, IF: 1:1,000), rabbit antiâGAPDH (14C10, Cell Signaling, WB: 1:2,000), rabbit antiâLC3 (2220, Novus Biologicals, WB: 1:1,000), mouse antiâp62 (610833, BD Biosciences, IF: 1:1,000), rabbit antiâp62 (18420â1âAP, ProteinTech, IF: 1:200), rabbit antiâFIP200 (SAB4200135, Sigma, WB: 1:500), rabbit antiâULK1 (#8054, Cell Signaling, WB: 1:1,000), rabbit antiâphosphoâULK S757 (#6888, Cell Signaling, WB: 1:1,000), mouse antiâEGFP (JL8, Clontech, WB: 1:5,000), rabbit antiâATG13 (#6940, Cell Signaling, WB: 1:1,000), rabbit antiâRab1a (Ab97956 Abcam, WB: 1:1,000), and rabbit antiâHA (Sigma, WB: 1:2,000, IF: 1:1,000). Secondary antibodies used for immunoblotting were horseradish peroxidaseâcoupled goat antiârabbit, goat antiârat, and rabbit antiâmouse IgG (Dako; 1:5,000). Secondary antibodies used for immunofluorescence were Alexa fluorophore (488, 568, or 633)âcoupled goat/donkey antiâmouse IgG, Alexa fluorophore (488, 568, or 633)âcoupled goat/donkey antiârabbit IgG (Invitrogen; 1:500).</p>
      </sec>
      <sec id="embj201694401-sec-0022">
        <title>RNA extraction and RTâqPCR</title>
        <p>RNA was extracted from HEK293, HeLa, SHâSY5Y, rat cortical neurons, or iNeuron cells using TRIzol reagent (Invitrogen), according to the manufacturer's instructions. Extracted RNA was dissolved in 20Â Î¼l of nucleaseâfree water. RNA from wholeâcell extraction was reverseâtranscribed into cDNA using Superscript III reverse transcriptase (Invitrogen). 2Â Î¼g RNA was transcribed in a final volume of 10Â Î¼l with 2Â Î¼l of 25Â mM dNTP mix (NEB), 4Â Î¼l of 5ÃÂ reverse transcriptase buffer (Invitrogen), 2Â Î¼l of 0.1Â M DTT, 1Â Î¼l of Superscript III, and 1Â Î¼l of Oligo(dT) (Thermo Scientific). RTâqPCR was performed using the Stratagene Mx3000P and MxPro v4.10 software. Samples were amplified in triplicate in 20Â Î¼l volumes using SYBRâGreen master mix and 250Â nM of each optimized forward and reverse primer. Cycling conditions for RTâqPCR were as follows: 95Â°C for 10Â min to denature followed by 35 cycles of 95Â°C for 30Â s, 60Â°C for 1Â min. Levels of mRNA were quantified relative to GAPDH mRNA levels according to the ÎÎC<italic>t</italic> method.</p>
        <p>Primer sequences were as follows: human C9orf72 (all isoforms), FW gttgatagattaacacatataatccgg, REV cagtaagcattggaataatactctga; human Rab1a, FW tgtccagcatgaatcccgaa, REV ggcaagactttccaacccct; human GAPDH, FW gggtggggctcatttgcaggg, REV tgggggcatcagcagagggg; rat GAPDH FW: tgaagggtggggccaaaagg, REV ggtcatgagcccttccatga; and rat C9orf72 FW: gtgttgacaggctaacgcac, REV: agggatgacctccccagtaa.</p>
      </sec>
      <sec id="embj201694401-sec-0023">
        <title>Induction of autophagy</title>
        <p>Autophagy was induced by incubation with 500Â nM rapamycin for 6Â h or 250Â nM Torin1 for 3Â h. Autophagy was blocked by addition of 100Â nM bafilomycin A1 for 5 (neurons) or 6Â h. Where cells were treated with Torin1 and bafilomycin A1, Torin1 was added 2 (neurons) or 3Â h after addition of bafilomycin A1.</p>
      </sec>
      <sec id="embj201694401-sec-0024">
        <title>Yeast 2 hybrid</title>
        <p>C9orf72S was cloned as âbaitâ fused to the DNA binding domain of GAL4 in pGBKT7 using EcoRI/BamHI restriction sites and was used to screen a human brain random cDNA library. Screens were performed by Protein Interaction Screening, Genomics and Proteomics Core Facilities (W150), German Cancer Research Center (DKFZ), Heidelberg, Germany.</p>
      </sec>
      <sec id="embj201694401-sec-0025">
        <title>Immunofluorescence</title>
        <p>Immunostaining was performed as described previously (De Vos <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0012" ref-type="ref">2005</xref>). Briefly, cells grown on glass coverslips were fixed with 3.7% formaldehyde in phosphateâbuffered saline (PBS) for 20Â min at room temperature. After washing with PBS, residual formaldehyde was quenched by incubation with 50Â mM NH<sub>4</sub>Cl in PBS for 10Â min at room temperature, followed by a second round of washing with PBS. Subsequently, the cells were permeabilized by incubation with 0.2% Triton Xâ100 in PBS for 3Â min. Triton Xâ100 was removed by washing with PBS. After fixing, the cells were incubated with PBS containing 0.2% fish gelatin (PBS/F) for 30Â min at room temperature (cell lines) or PBS containing 2% fish gelatin for 1â2Â h (neurons) and then with the primary antibody in PBS/F for 1Â h at RT or ON at 4Â°C. After washing with PBS/F, the cells were incubated with secondary antibody in PBS/F for 45Â min at room temperature and stained with Hoechst 33342. After a final wash, the samples were mounted in fluorescence mounting medium (Dako).</p>
        <p>Images were recorded using appropriate filtersets (Omega Optical and Chroma Technology) using MicroManager 1.4 software (Edelstein <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0020" ref-type="ref">2014</xref>) on a Zeiss Axioplan2 microscope fitted with a Hamamatsu C4880â80 or Retiga R3 (QImaging) CCD camera, PEâ300 LED illumination (CoolLED), and a 63Ã, 1.4NA Plan Apochromat objective (Zeiss) or on a Zeiss Axiovert 200 microscope equipped with a Hamamatsu C9100â12 EMCCD, PEâ4000 LED illumination (CoolLED), and 63Ã, 1.4NA Plan Apochromat and 100Ã, 1.3NA Plan Apochromat objectives (Zeiss) and using MetaMorph software (Universal Imaging) on an Olympus IX83 equipped with a Zyla4.2 sCMOS camera (Andor), SpectraX light engine (Lumencor) and OptoLED (Cairn Research) illumination, and 60Ã, 1.35NA Universal Plan Super Apochromat and 40Ã, 1.35NA Universal Apochromat objectives (Olympus). Illumination intensities, exposure times, and camera settings were kept constant during experiments.</p>
      </sec>
      <sec id="embj201694401-sec-0026">
        <title>Proximity ligation assay</title>
        <p>
<italic>In situ</italic> proximity ligation assays were performed with the Duolink <italic>In Situ</italic> Kit following the manufacturer's protocol (Olink Bioscience). Twentyâfour hours postâtransfection, cells were fixed, quenched, and permeabilized. Samples were blocked according to the manufacturer's instructions. Samples were then probed with primary antibodies for 1Â h at room temperature. After washing, cells were incubated with mouseâminus and rabbitâplus PLA probes according to the manufacturer's instructions for 1Â h at 37Â°C. After further washes, the PLA probes were ligated for 30Â min at 37Â°C before the amplification step was performed for 100Â min at 37Â°C using the Duolink Orange detection reagents. After final washes, the samples were mounted in fluorescence mounting medium (Dako).</p>
      </sec>
      <sec id="embj201694401-sec-0027">
        <title>Image analysis</title>
        <p>All image analysis was performed using ImageJ (Abramoff <italic>etÂ al</italic>, <xref rid="embj201694401-bib-0001" ref-type="ref">2004</xref>). mCherryâFIP200, EGFPâLC3, mCherryâEGFPâLC3, p62 puncta, and PLA proximity signals were counted in single cells using the Particle Analysis facility of ImageJ. Where possible, the cells for analysis were selected based on fluorescence in the other channel, else the samples were blinded to the operator. Images were filtered using a Hat filter (7Â ÃÂ 7 kernel) (De Vos &amp; Sheetz, <xref rid="embj201694401-bib-0013" ref-type="ref">2007</xref>) to extract puncta and proximity signals and thresholded such that the visible puncta within the cell were highlighted, but no background was included. The result of thresholding was further checked against the original image to ensure no background signal was identified as puncta or signals were lost. In case of mCherryâEGFPâLC3, puncta in the red and green channels were counted separately. Redâonly puncta were determined by subtracting the green puncta from the red puncta.</p>
      </sec>
      <sec id="embj201694401-sec-0028">
        <title>Statistical analysis</title>
        <p>Calculations and statistical analysis were performed using Excel (Microsoft Corporation, Redmond, WA) and Prism 6 software (GraphPad Software Inc., San Diego, CA).</p>
      </sec>
    </sec>
    <sec id="embj201694401-sec-0030">
      <title>Author contributions</title>
      <p>CPW, EFS, CSB, LF, MM, GMH, AH, MJW, AM, AJG, and KJDV performed experiments. BKK, KM, and PJS provided reagents. AJG and KJDV designed experiments. CPW, EFS, CSB, LF, AM, and KJDV wrote the manuscript. GMH, PJS, AJW, BKK, KM, and AJG edited the manuscript. KJDV supervised the research.</p>
    </sec>
    <sec id="embj201694401-sec-0031">
      <title>Conflict of interest</title>
      <p>The authors declare that they have no conflict of interest.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supporting information</title>
      <supplementary-material content-type="local-data"/>
      <supplementary-material content-type="local-data" id="embj201694401-sup-0001">
        <caption>
          <p>Appendix</p>
        </caption>
        <media xlink:href="EMBJ-35-1656-s001.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="embj201694401-sup-0002">
        <caption>
          <p>Expanded View Figures PDF</p>
        </caption>
        <media xlink:href="EMBJ-35-1656-s002.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data">
        <caption>
          <p>Review Process File</p>
        </caption>
        <media xlink:href="EMBJ-35-1656-s009.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="embj201694401-supp-data-0001">
        <caption>
          <p>Source Data for FigureÂ 1</p>
        </caption>
        <media xlink:href="EMBJ-35-1656-s003.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="embj201694401-supp-data-0002">
        <caption>
          <p>Source Data for FigureÂ 2</p>
        </caption>
        <media xlink:href="EMBJ-35-1656-s004.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="embj201694401-supp-data-0003">
        <caption>
          <p>Source Data for FigureÂ 3</p>
        </caption>
        <media xlink:href="EMBJ-35-1656-s005.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="embj201694401-supp-data-0004">
        <caption>
          <p>Source Data for FigureÂ 4</p>
        </caption>
        <media xlink:href="EMBJ-35-1656-s006.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="embj201694401-supp-data-0005">
        <caption>
          <p>Source Data for FigureÂ 6</p>
        </caption>
        <media xlink:href="EMBJ-35-1656-s007.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="embj201694401-supp-data-0006">
        <caption>
          <p>Source Data for FigureÂ 9</p>
        </caption>
        <media xlink:href="EMBJ-35-1656-s008.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="embj201694401-sec-0029">
      <title>Acknowledgements</title>
      <p>We thank Noburo Mizushima (Tokyo Medical and Dental University, Japan), Xuejun Jiang (Memorial SloanâKettering Cancer Center, NYC, USA), DoâHyung Kim (University of Minnesota), T HÃ©bert (McGill University, Canada), Terje Johansen (University of TromsÃ¸, Norway), and Chris Miller (KCL, UK) for the sharing of reagents. This work was funded by grants from the Thierry Latran Foundation (Project RoCIP to KJDV, AJG, PJS), Medical Research Council (MRC) (MR/K005146/1 to KJDV and MR/M013251/1 to KJDV, AJW), Alzheimer's Society (260 (ASâPGâ15â023) to KJDV, CPW, AJG), the University of Sheffield Moody Family Endowment (to KJDV, CPW), and a EU Framework 7 Award (Euromotor No 259867 to PJS). PJS is supported as an NIHR Senior Investigator. EFS is supported by a Motor Neurone Disease Association Prize Studentship (DeVos/Oct13/870â892 to KJDV, AJG). LF is supported by a Marie Curie International Fellowship (EU framework 7 grant 303101).</p>
    </ack>
    <ref-list content-type="cited-references" id="embj201694401-bibl-0001">
      <title>References</title>
      <ref id="embj201694401-bib-0001">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0001">
<string-name>
<surname>Abramoff</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>MagalhÃ£es</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Ram</surname>
<given-names>SJ</given-names>
</string-name> (<year>2004</year>) <article-title>Image Processing with ImageJ</article-title>. <source>Biophotonics Int</source>
<volume>11</volume>: <fpage>36</fpage>â<lpage>42</lpage>
</mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0002">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0002">
<string-name>
<surname>Alers</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Loffler</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Paasch</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Dieterle</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Keppeler</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lauber</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Campbell</surname>
<given-names>DG</given-names>
</string-name>, <string-name>
<surname>Fehrenbacher</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Schaller</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wesselborg</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Stork</surname>
<given-names>B</given-names>
</string-name> (<year>2011</year>) <article-title>Atg13 and FIP200 act independently of Ulk1 and Ulk2 in autophagy induction</article-title>. <source>Autophagy</source>
<volume>7</volume>: <fpage>1423</fpage>â<lpage>1433</lpage>
<pub-id pub-id-type="pmid">22024743</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0003">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0003">
<string-name>
<surname>AlâSarraj</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>King</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Troakes</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Maekawa</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bodi</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Rogelj</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>AlâChalabi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hortobagyi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Shaw</surname>
<given-names>CE</given-names>
</string-name> (<year>2011</year>) <article-title>p62 positive, TDPâ43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72âlinked FTLD and MND/ALS</article-title>. <source>Acta Neuropathol</source>
<volume>122</volume>: <fpage>691</fpage>â<lpage>702</lpage>
<pub-id pub-id-type="pmid">22101323</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0004">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0004">
<string-name>
<surname>Ao</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zou</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>Y</given-names>
</string-name> (<year>2014</year>) <article-title>Regulation of autophagy by the Rab GTPase network</article-title>. <source>Cell Death Differ</source>
<volume>21</volume>: <fpage>348</fpage>â<lpage>358</lpage>
<pub-id pub-id-type="pmid">24440914</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0005">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0005">
<string-name>
<surname>Ash</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Bieniek</surname>
<given-names>KF</given-names>
</string-name>, <string-name>
<surname>Gendron</surname>
<given-names>TF</given-names>
</string-name>, <string-name>
<surname>Caulfield</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>WL</given-names>
</string-name>, <string-name>
<surname>DejesusâHernandez</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>van Blitterswijk</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>JansenâWest</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Paul</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Boylan</surname>
<given-names>KB</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Petrucelli</surname>
<given-names>L</given-names>
</string-name> (<year>2013</year>) <article-title>Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS</article-title>. <source>Neuron</source>
<volume>77</volume>: <fpage>639</fpage>â<lpage>646</lpage>
<pub-id pub-id-type="pmid">23415312</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0006">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0006">
<string-name>
<surname>Atanasio</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Decman</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>White</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ramos</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ikiz</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>HC</given-names>
</string-name>, <string-name>
<surname>Siao</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Brydges</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>LaRosa</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Bai</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Fury</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Burfeind</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Zamfirova</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Warshaw</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Orengo</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Oyejide</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Fralish</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Auerbach</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Poueymirou</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Freudenberg</surname>
<given-names>J</given-names>
</string-name>
<italic>etÂ al</italic> (<year>2016</year>) <article-title>C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice</article-title>. <source>Sci Rep</source>
<volume>6</volume>: <fpage>23204</fpage>
<pub-id pub-id-type="pmid">26979938</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0007">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0007">
<string-name>
<surname>Behrends</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Sowa</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Gygi</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Harper</surname>
<given-names>JW</given-names>
</string-name> (<year>2010</year>) <article-title>Network organization of the human autophagy system</article-title>. <source>Nature</source>
<volume>466</volume>: <fpage>68</fpage>â<lpage>76</lpage>
<pub-id pub-id-type="pmid">20562859</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0008">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0008">
<string-name>
<surname>Belzil</surname>
<given-names>VV</given-names>
</string-name>, <string-name>
<surname>Bauer</surname>
<given-names>PO</given-names>
</string-name>, <string-name>
<surname>Prudencio</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gendron</surname>
<given-names>TF</given-names>
</string-name>, <string-name>
<surname>Stetler</surname>
<given-names>CT</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>IK</given-names>
</string-name>, <string-name>
<surname>Pregent</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Daughrity</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Baker</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Boylan</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>TC</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Petrucelli</surname>
<given-names>L</given-names>
</string-name> (<year>2013</year>) <article-title>Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood</article-title>. <source>Acta Neuropathol</source>
<volume>126</volume>: <fpage>895</fpage>â<lpage>905</lpage>
<pub-id pub-id-type="pmid">24166615</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0009">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0009">
<string-name>
<surname>Chen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Le</surname>
<given-names>W</given-names>
</string-name> (<year>2012</year>) <article-title>Autophagy dysregulation in amyotrophic lateral sclerosis</article-title>. <source>Brain Pathol</source>
<volume>22</volume>: <fpage>110</fpage>â<lpage>116</lpage>
<pub-id pub-id-type="pmid">22150926</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0010">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0010">
<string-name>
<surname>Ciura</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lattante</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Le Ber</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Latouche</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tostivint</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Brice</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kabashi</surname>
<given-names>E</given-names>
</string-name> (<year>2013</year>) <article-title>Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis</article-title>. <source>Ann Neurol</source>
<volume>74</volume>: <fpage>180</fpage>â<lpage>187</lpage>
<pub-id pub-id-type="pmid">23720273</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0011">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0011">
<string-name>
<surname>CooperâKnock</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hewitt</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Highley</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Brockington</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Milano</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Man</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Martindale</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hartley</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Walsh</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Gelsthorpe</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Baxter</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Forster</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Fox</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bury</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Mok</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>McDermott</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Traynor</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Kirby</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wharton</surname>
<given-names>SB</given-names>
</string-name>, <string-name>
<surname>Ince</surname>
<given-names>PG</given-names>
</string-name>
<italic>etÂ al</italic> (<year>2012</year>) <article-title>Clinicoâpathological features in amyotrophic lateral sclerosis with expansions in C9ORF72</article-title>. <source>Brain</source>
<volume>135</volume>: <fpage>751</fpage>â<lpage>764</lpage>
<pub-id pub-id-type="pmid">22366792</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0012">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0012">
<string-name>
<surname>De Vos</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Allan</surname>
<given-names>VJ</given-names>
</string-name>, <string-name>
<surname>Grierson</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Sheetz</surname>
<given-names>MP</given-names>
</string-name> (<year>2005</year>) <article-title>Mitochondrial function and actin regulate dynaminârelated protein 1âdependent mitochondrial fission</article-title>. <source>Curr Biol</source>
<volume>15</volume>: <fpage>678</fpage>â<lpage>683</lpage>
<pub-id pub-id-type="pmid">15823542</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0013">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0013">
<string-name>
<surname>De Vos</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Sheetz</surname>
<given-names>MP</given-names>
</string-name> (<year>2007</year>) <article-title>Visualization and quantification of mitochondrial dynamics in living animal cells</article-title>. <source>Methods Cell Biol</source>
<volume>80</volume>: <fpage>627</fpage>â<lpage>682</lpage>
<pub-id pub-id-type="pmid">17445716</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0014">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0014">
<string-name>
<surname>DÃ©glon</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Tseng</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Bensadoun</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Zurn</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Arsenijevic</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Pereira de Almeida</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zufferey</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Trono</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Aebischer</surname>
<given-names>P</given-names>
</string-name> (<year>2000</year>) <article-title>Selfâinactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease</article-title>. <source>Hum Gene Ther</source>
<volume>11</volume>: <fpage>179</fpage>â<lpage>190</lpage>
<pub-id pub-id-type="pmid">10646649</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0015">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0015">
<string-name>
<surname>DeJesusâHernandez</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mackenzie</surname>
<given-names>IR</given-names>
</string-name>, <string-name>
<surname>Boeve</surname>
<given-names>BF</given-names>
</string-name>, <string-name>
<surname>Boxer</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Baker</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rutherford</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Nicholson</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Finch</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Flynn</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Adamson</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kouri</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Wojtas</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sengdy</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Hsiung</surname>
<given-names>GY</given-names>
</string-name>, <string-name>
<surname>Karydas</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Seeley</surname>
<given-names>WW</given-names>
</string-name>, <string-name>
<surname>Josephs</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Coppola</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Wszolek</surname>
<given-names>ZK</given-names>
</string-name>
<italic>etÂ al</italic> (<year>2011</year>) <article-title>Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9pâlinked FTD and ALS</article-title>. <source>Neuron</source>
<volume>72</volume>: <fpage>245</fpage>â<lpage>256</lpage>
<pub-id pub-id-type="pmid">21944778</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0016">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0016">
<string-name>
<surname>Donnelly</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>PW</given-names>
</string-name>, <string-name>
<surname>Pham</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Haeusler</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Mistry</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Vidensky</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Daley</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Poth</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Hoover</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Fines</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Maragakis</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Tienari</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Petrucelli</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Traynor</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Rigo</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Bennett</surname>
<given-names>CF</given-names>
</string-name>, <string-name>
<surname>Blackshaw</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sattler</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Rothstein</surname>
<given-names>JD</given-names>
</string-name> (<year>2013</year>) <article-title>RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention</article-title>. <source>Neuron</source>
<volume>80</volume>: <fpage>415</fpage>â<lpage>428</lpage>
<pub-id pub-id-type="pmid">24139042</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0017">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0017">
<string-name>
<surname>Dou</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Dbouk</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Ballou</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>DeLeon</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Fan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Backer</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>RZ</given-names>
</string-name>, <string-name>
<surname>Zong</surname>
<given-names>WX</given-names>
</string-name> (<year>2013</year>) <article-title>Class IA PI3K p110beta subunit promotes autophagy through Rab5 small GTPase in response to growth factor limitation</article-title>. <source>Mol Cell</source>
<volume>50</volume>: <fpage>29</fpage>â<lpage>42</lpage>
<pub-id pub-id-type="pmid">23434372</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0018">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0018">
<string-name>
<surname>Dull</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Zufferey</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kelly</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mandel</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Trono</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Naldini</surname>
<given-names>L</given-names>
</string-name> (<year>1998</year>) <article-title>A thirdâgeneration lentivirus vector with a conditional packaging system</article-title>. <source>J Virol</source>
<volume>72</volume>: <fpage>8463</fpage>â<lpage>8471</lpage>
<pub-id pub-id-type="pmid">9765382</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0019">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0019">
<string-name>
<surname>Dupre</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Robitaille</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ethier</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Villeneuve</surname>
<given-names>LR</given-names>
</string-name>, <string-name>
<surname>Mamarbachi</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Hebert</surname>
<given-names>TE</given-names>
</string-name> (<year>2006</year>) <article-title>Seven transmembrane receptor core signaling complexes are assembled prior to plasma membrane trafficking</article-title>. <source>J Biol Chem</source>
<volume>281</volume>: <fpage>34561</fpage>â<lpage>34573</lpage>
<pub-id pub-id-type="pmid">16959776</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0020">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0020">
<string-name>
<surname>Edelstein</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Tsuchida</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Amodaj</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Pinkard</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Vale</surname>
<given-names>RD</given-names>
</string-name>, <string-name>
<surname>Stuurman</surname>
<given-names>N</given-names>
</string-name> (<year>2014</year>) <article-title>Advanced methods of microscope control using Î¼Manager software</article-title>. <source>J Biol Methods</source>
<volume>1</volume>: <fpage>e10</fpage>
<pub-id pub-id-type="pmid">25606571</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0021">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0021">
<string-name>
<surname>Farg</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Sundaramoorthy</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Sultana</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Atkinson</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Levina</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Halloran</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Gleeson</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Blair</surname>
<given-names>IP</given-names>
</string-name>, <string-name>
<surname>Soo</surname>
<given-names>KY</given-names>
</string-name>, <string-name>
<surname>King</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Atkin</surname>
<given-names>JD</given-names>
</string-name> (<year>2014</year>) <article-title>C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking</article-title>. <source>Hum Mol Genet</source>
<volume>23</volume>: <fpage>3579</fpage>â<lpage>3595</lpage>
<pub-id pub-id-type="pmid">24549040</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0022">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0022">
<string-name>
<surname>Ganley</surname>
<given-names>IG</given-names>
</string-name>, <string-name>
<surname>du Lam</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>X</given-names>
</string-name> (<year>2009</year>) <article-title>ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy</article-title>. <source>J Biol Chem</source>
<volume>284</volume>: <fpage>12297</fpage>â<lpage>12305</lpage>
<pub-id pub-id-type="pmid">19258318</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0023">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0023">
<string-name>
<surname>Gendron</surname>
<given-names>TF</given-names>
</string-name>, <string-name>
<surname>Bieniek</surname>
<given-names>KF</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>YJ</given-names>
</string-name>, <string-name>
<surname>JansenâWest</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ash</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Caulfield</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Daughrity</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Dunmore</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>CastanedesâCasey</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chew</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cosio</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>van Blitterswijk</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>WC</given-names>
</string-name>, <string-name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Boylan</surname>
<given-names>KB</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Petrucelli</surname>
<given-names>L</given-names>
</string-name> (<year>2013</year>) <article-title>Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeatâassociated nonâATG translation in c9FTD/ALS</article-title>. <source>Acta Neuropathol</source>
<volume>126</volume>: <fpage>829</fpage>â<lpage>844</lpage>
<pub-id pub-id-type="pmid">24129584</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0024">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0024">
<string-name>
<surname>Gijselinck</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Van Langenhove</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>van der Zee</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sleegers</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Philtjens</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kleinberger</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Janssens</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Bettens</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Van Cauwenberghe</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Pereson</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Engelborghs</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sieben</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>De Jonghe</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Vandenberghe</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Santens</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>De Bleecker</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Maes</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Baumer</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Dillen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Joris</surname>
<given-names>G</given-names>
</string-name>
<italic>etÂ al</italic> (<year>2012</year>) <article-title>A C9orf72 promoter repeat expansion in a FlandersâBelgian cohort with disorders of the frontotemporal lobar degenerationâamyotrophic lateral sclerosis spectrum: a gene identification study</article-title>. <source>Lancet Neurol</source>
<volume>11</volume>: <fpage>54</fpage>â<lpage>65</lpage>
<pub-id pub-id-type="pmid">22154785</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0025">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0025">
<string-name>
<surname>Gijselinck</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Van Mossevelde</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>van der Zee</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sieben</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Engelborghs</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>De Bleecker</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ivanoiu</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Deryck</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Edbauer</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Heeman</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>BÃ¤umer</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Van den Broeck</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mattheijssens</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Peeters</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Rogaeva</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>De Jonghe</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Cras</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Martin</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>de Deyn</surname>
<given-names>PP</given-names>
</string-name>
<italic>etÂ al</italic> (<year>2015</year>) <article-title>The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter</article-title>. <source>Mol Psychiatry</source> doi: <ext-link ext-link-type="doi" xlink:href="10.1038/mp.2015.159">10.1038/mp.2015.159</ext-link>
</mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0026">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0026">
<string-name>
<surname>Hara</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nakamura</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Matsui</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Nakahara</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>SuzukiâMigishima</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Yokoyama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mishima</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Saito</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Okano</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Mizushima</surname>
<given-names>N</given-names>
</string-name> (<year>2006</year>) <article-title>Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice</article-title>. <source>Nature</source>
<volume>441</volume>: <fpage>885</fpage>â<lpage>889</lpage>
<pub-id pub-id-type="pmid">16625204</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0027">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0027">
<string-name>
<surname>Hara</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Takamura</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kishi</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Iemura</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Natsume</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Guan</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Mizushima</surname>
<given-names>N</given-names>
</string-name> (<year>2008</year>) <article-title>FIP200, a ULKâinteracting protein, is required for autophagosome formation in mammalian cells</article-title>. <source>J Cell Biol</source>
<volume>181</volume>: <fpage>497</fpage>â<lpage>510</lpage>
<pub-id pub-id-type="pmid">18443221</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0028">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0028">
<string-name>
<surname>Harris</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Rubinsztein</surname>
<given-names>DC</given-names>
</string-name> (<year>2012</year>) <article-title>Control of autophagy as a therapy for neurodegenerative disease</article-title>. <source>Nat Rev Neurol</source>
<volume>8</volume>: <fpage>108</fpage>â<lpage>117</lpage>
<pub-id pub-id-type="pmid">22187000</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0029">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0029">
<string-name>
<surname>Hutagalung</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Novick</surname>
<given-names>PJ</given-names>
</string-name> (<year>2011</year>) <article-title>Role of Rab GTPases in membrane traffic and cell physiology</article-title>. <source>Physiol Rev</source>
<volume>91</volume>: <fpage>119</fpage>â<lpage>149</lpage>
<pub-id pub-id-type="pmid">21248164</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0030">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0030">
<string-name>
<surname>Jung</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Jun</surname>
<given-names>CB</given-names>
</string-name>, <string-name>
<surname>Ro</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>YM</given-names>
</string-name>, <string-name>
<surname>Otto</surname>
<given-names>NM</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kundu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>DH</given-names>
</string-name> (<year>2009</year>) <article-title>ULKâAtg13âFIP200 complexes mediate mTOR signaling to the autophagy machinery</article-title>. <source>Mol Biol Cell</source>
<volume>20</volume>: <fpage>1992</fpage>â<lpage>2003</lpage>
<pub-id pub-id-type="pmid">19225151</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0031">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0031">
<string-name>
<surname>Kim</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kundu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Viollet</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Guan</surname>
<given-names>KL</given-names>
</string-name> (<year>2011</year>) <article-title>AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1</article-title>. <source>Nat Cell Biol</source>
<volume>13</volume>: <fpage>132</fpage>â<lpage>141</lpage>
<pub-id pub-id-type="pmid">21258367</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0032">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0032">
<string-name>
<surname>Kimura</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Noda</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yoshimori</surname>
<given-names>T</given-names>
</string-name> (<year>2007</year>) <article-title>Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescentâtagged LC3</article-title>. <source>Autophagy</source>
<volume>3</volume>: <fpage>452</fpage>â<lpage>460</lpage>
<pub-id pub-id-type="pmid">17534139</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0033">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0033">
<string-name>
<surname>Komatsu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Waguri</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chiba</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Murata</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Iwata</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tanida</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Ueno</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Koike</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Uchiyama</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kominami</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>K</given-names>
</string-name> (<year>2006</year>) <article-title>Loss of autophagy in the central nervous system causes neurodegeneration in mice</article-title>. <source>Nature</source>
<volume>441</volume>: <fpage>880</fpage>â<lpage>884</lpage>
<pub-id pub-id-type="pmid">16625205</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0034">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0034">
<string-name>
<surname>Koppers</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Blokhuis</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Westeneng</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Terpstra</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Zundel</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Vieira de SÃ¡</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Schellevis</surname>
<given-names>RD</given-names>
</string-name>, <string-name>
<surname>Waite</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Blake</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Veldink</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>van den Berg</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>Pasterkamp</surname>
<given-names>RJ</given-names>
</string-name> (<year>2015</year>) <article-title>C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits</article-title>. <source>Ann Neurol</source>
<volume>78</volume>: <fpage>426</fpage>â<lpage>438</lpage>
<pub-id pub-id-type="pmid">26044557</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0035">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0035">
<string-name>
<surname>LagierâTourenne</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Baughn</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rigo</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>HR</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Watt</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Chun</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Katz</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Qiu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ling</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Polymenidou</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Drenner</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Artates</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>McAlonisâDownes</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Markmiller</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hutt</surname>
<given-names>KR</given-names>
</string-name>
<italic>etÂ al</italic> (<year>2013</year>) <article-title>Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>110</volume>: <fpage>E4530</fpage>â<lpage>E4539</lpage>
<pub-id pub-id-type="pmid">24170860</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0036">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0036">
<string-name>
<surname>Levine</surname>
<given-names>TP</given-names>
</string-name>, <string-name>
<surname>Daniels</surname>
<given-names>RD</given-names>
</string-name>, <string-name>
<surname>Gatta</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>Hayes</surname>
<given-names>MJ</given-names>
</string-name> (<year>2013</year>) <article-title>The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN RabâGEFs</article-title>. <source>Bioinformatics</source>
<volume>29</volume>: <fpage>499</fpage>â<lpage>503</lpage>
<pub-id pub-id-type="pmid">23329412</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0037">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0037">
<string-name>
<surname>Liang</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Gan</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Guan</surname>
<given-names>JL</given-names>
</string-name> (<year>2010</year>) <article-title>Neuralâspecific deletion of FIP200 leads to cerebellar degeneration caused by increased neuronal death and axon degeneration</article-title>. <source>J Biol Chem</source>
<volume>285</volume>: <fpage>3499</fpage>â<lpage>3509</lpage>
<pub-id pub-id-type="pmid">19940130</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0038">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0038">
<string-name>
<surname>Lipatova</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Segev</surname>
<given-names>N</given-names>
</string-name> (<year>2012</year>) <article-title>A Ypt/Rab GTPase module makes a PAS</article-title>. <source>Autophagy</source>
<volume>8</volume>: <fpage>1271</fpage>â<lpage>1272</lpage>
<pub-id pub-id-type="pmid">22669536</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0039">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0039">
<string-name>
<surname>LynchâDay</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Bhandari</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Menon</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Bartholomew</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Brumell</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>FerroâNovick</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Klionsky</surname>
<given-names>DJ</given-names>
</string-name> (<year>2010</year>) <article-title>Trs85 directs a Ypt1 GEF, TRAPPIII, to the phagophore to promote autophagy</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>107</volume>: <fpage>7811</fpage>â<lpage>7816</lpage>
<pub-id pub-id-type="pmid">20375281</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0040">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0040">
<string-name>
<surname>Mackenzie</surname>
<given-names>IR</given-names>
</string-name>, <string-name>
<surname>Frick</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Neumann</surname>
<given-names>M</given-names>
</string-name> (<year>2014</year>) <article-title>The neuropathology associated with repeat expansions in the C9ORF72 gene</article-title>. <source>Acta Neuropathol</source>
<volume>127</volume>: <fpage>347</fpage>â<lpage>357</lpage>
<pub-id pub-id-type="pmid">24356984</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0041">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0041">
<string-name>
<surname>Majounie</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Renton</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Mok</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Dopper</surname>
<given-names>EG</given-names>
</string-name>, <string-name>
<surname>Waite</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rollinson</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chio</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Restagno</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Nicolaou</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>SimonâSanchez</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>van Swieten</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Abramzon</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>JO</given-names>
</string-name>, <string-name>
<surname>Sendtner</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pamphlett</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Orrell</surname>
<given-names>RW</given-names>
</string-name>, <string-name>
<surname>Mead</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sidle</surname>
<given-names>KC</given-names>
</string-name>, <string-name>
<surname>Houlden</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Rohrer</surname>
<given-names>JD</given-names>
</string-name>
<italic>etÂ al</italic> (<year>2012</year>) <article-title>Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a crossâsectional study</article-title>. <source>Lancet Neurol</source>
<volume>11</volume>: <fpage>323</fpage>â<lpage>330</lpage>
<pub-id pub-id-type="pmid">22406228</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0042">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0042">
<string-name>
<surname>Meyer</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ferraiuolo</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Miranda</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Likhite</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>McElroy</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Renusch</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ditsworth</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>LagierâTourenne</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Ravits</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Burghes</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Shaw</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Cleveland</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Kolb</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Kaspar</surname>
<given-names>BK</given-names>
</string-name> (<year>2014</year>) <article-title>Direct conversion of patient fibroblasts demonstrates nonâcell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>111</volume>: <fpage>829</fpage>â<lpage>832</lpage>
<pub-id pub-id-type="pmid">24379375</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0043">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0043">
<string-name>
<surname>Mizielinska</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lashley</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Norona</surname>
<given-names>FE</given-names>
</string-name>, <string-name>
<surname>Clayton</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Ridler</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Fratta</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Isaacs</surname>
<given-names>AM</given-names>
</string-name> (<year>2013</year>) <article-title>C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci</article-title>. <source>Acta Neuropathol</source>
<volume>126</volume>: <fpage>845</fpage>â<lpage>857</lpage>
<pub-id pub-id-type="pmid">24170096</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0044">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0044">
<string-name>
<surname>Mizielinska</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gronke</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Niccoli</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ridler</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Clayton</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Devoy</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Moens</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Norona</surname>
<given-names>FE</given-names>
</string-name>, <string-name>
<surname>Woollacott</surname>
<given-names>IO</given-names>
</string-name>, <string-name>
<surname>Pietrzyk</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cleverley</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nicoll</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>PickeringâBrown</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dols</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cabecinha</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hendrich</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Fratta</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Fisher</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Partridge</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Isaacs</surname>
<given-names>AM</given-names>
</string-name> (<year>2014</year>) <article-title>C9orf72 repeat expansions cause neurodegeneration in <italic>Drosophila</italic> through arginineârich proteins</article-title>. <source>Science</source>
<volume>345</volume>: <fpage>1192</fpage>â<lpage>1194</lpage>
<pub-id pub-id-type="pmid">25103406</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0045">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0045">
<string-name>
<surname>Mori</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Arzberger</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Grasser</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Gijselinck</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>May</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rentzsch</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Weng</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Schludi</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>van der Zee</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cruts</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Van Broeckhoven</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Kremmer</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kretzschmar</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Haass</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Edbauer</surname>
<given-names>D</given-names>
</string-name> (<year>2013a</year>) <article-title>Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins</article-title>. <source>Acta Neuropathol</source>
<volume>126</volume>: <fpage>881</fpage>â<lpage>893</lpage>
<pub-id pub-id-type="pmid">24132570</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0046">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0046">
<string-name>
<surname>Mori</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Weng</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Arzberger</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>May</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rentzsch</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kremmer</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Schmid</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Kretzschmar</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Cruts</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Van Broeckhoven</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Haass</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Edbauer</surname>
<given-names>D</given-names>
</string-name> (<year>2013b</year>) <article-title>The C9orf72 GGGGCC repeat is translated into aggregating dipeptideârepeat proteins in FTLD/ALS</article-title>. <source>Science</source>
<volume>339</volume>: <fpage>1335</fpage>â<lpage>1338</lpage>
<pub-id pub-id-type="pmid">23393093</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0047">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0047">
<string-name>
<surname>Mukhopadhyay</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Nieves</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Che</surname>
<given-names>FY</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Murray</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Gordon</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Angeletti</surname>
<given-names>RH</given-names>
</string-name>, <string-name>
<surname>Wolkoff</surname>
<given-names>AW</given-names>
</string-name> (<year>2011</year>) <article-title>Proteomic analysis of endocytic vesicles: Rab1a regulates motility of early endocytic vesicles</article-title>. <source>J Cell Sci</source>
<volume>124</volume>: <fpage>765</fpage>â<lpage>775</lpage>
<pub-id pub-id-type="pmid">21303926</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0048">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0048">
<string-name>
<surname>Nanou</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Higginbottom</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Valori</surname>
<given-names>CF</given-names>
</string-name>, <string-name>
<surname>Wyles</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ning</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Shaw</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Azzouz</surname>
<given-names>M</given-names>
</string-name> (<year>2013</year>) <article-title>Viral delivery of antioxidant genes as a therapeutic strategy in experimental models of amyotrophic lateral sclerosis</article-title>. <source>Mol Ther</source>
<volume>21</volume>: <fpage>1486</fpage>â<lpage>1496</lpage>
<pub-id pub-id-type="pmid">23732987</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0049">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0049">
<string-name>
<surname>O'Rourke</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Bogdanik</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>YÃ¡Ã±ez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lall</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Wolf</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Muhammad</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Ho</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Carmona</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Vit</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Zarrow</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Bell</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Harms</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Dangler</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Underhill</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Goodridge</surname>
<given-names>HS</given-names>
</string-name>, <string-name>
<surname>Lutz</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Baloh</surname>
<given-names>RH</given-names>
</string-name> (<year>2016</year>) <article-title>C9orf72 is required for proper macrophage and microglial function in mice</article-title>. <source>Science</source>
<volume>351</volume>: <fpage>1324</fpage>â<lpage>1329</lpage>
<pub-id pub-id-type="pmid">26989253</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0050">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0050">
<string-name>
<surname>Pankiv</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Clausen</surname>
<given-names>TH</given-names>
</string-name>, <string-name>
<surname>Lamark</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Brech</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bruun</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Outzen</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Overvatn</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bjorkoy</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Johansen</surname>
<given-names>T</given-names>
</string-name> (<year>2007</year>) <article-title>p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy</article-title>. <source>J Biol Chem</source>
<volume>282</volume>: <fpage>24131</fpage>â<lpage>24145</lpage>
<pub-id pub-id-type="pmid">17580304</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0051">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0051">
<string-name>
<surname>Pollard</surname>
<given-names>TD</given-names>
</string-name> (<year>2010</year>) <article-title>A guide to simple and informative binding assays</article-title>. <source>Mol Biol Cell</source>
<volume>21</volume>: <fpage>4061</fpage>â<lpage>4067</lpage>
<pub-id pub-id-type="pmid">21115850</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0052">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0052">
<string-name>
<surname>Renton</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Majounie</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Waite</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>SimonâSanchez</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Rollinson</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gibbs</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Schymick</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Laaksovirta</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>van Swieten</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Myllykangas</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Kalimo</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Paetau</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Abramzon</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Remes</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Kaganovich</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Scholz</surname>
<given-names>SW</given-names>
</string-name>, <string-name>
<surname>Duckworth</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Harmer</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Hernandez</surname>
<given-names>DG</given-names>
</string-name>
<italic>etÂ al</italic> (<year>2011</year>) <article-title>A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21âlinked ALSâFTD</article-title>. <source>Neuron</source>
<volume>72</volume>: <fpage>257</fpage>â<lpage>268</lpage>
<pub-id pub-id-type="pmid">21944779</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0053">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0053">
<string-name>
<surname>Sareen</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>O'Rourke</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Meera</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Muhammad</surname>
<given-names>AKMG</given-names>
</string-name>, <string-name>
<surname>Grant</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Simpkinson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bell</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Carmona</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ornelas</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Sahabian</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gendron</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Petrucelli</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Baughn</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ravits</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Harms</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Rigo</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Bennett</surname>
<given-names>CF</given-names>
</string-name>, <string-name>
<surname>Otis</surname>
<given-names>TS</given-names>
</string-name>, <string-name>
<surname>Svendsen</surname>
<given-names>CN</given-names>
</string-name>, <string-name>
<surname>Baloh</surname>
<given-names>RH</given-names>
</string-name> (<year>2013</year>) <article-title>Targeting RNA foci in iPSCâderived motor neurons from ALS patients with a C9ORF72 repeat expansion</article-title>. <source>Science Trans Med</source>
<volume>5</volume>: <fpage>208ra149</fpage>
</mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0054">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0054">
<string-name>
<surname>Sellier</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Campanari</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Julie Corbier</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Gaucherot</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>KolbâCheynel</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>OuladâAbdelghani</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ruffenach</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Page</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ciura</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kabashi</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>CharletâBerguerand</surname>
<given-names>N</given-names>
</string-name> (<year>2016</year>) <article-title>Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxinâ2 to induce motor neuron dysfunction and cell death</article-title>. <source>EMBO J</source>
<volume>35</volume>: <fpage>1276</fpage>â<lpage>1297</lpage>
<pub-id pub-id-type="pmid">27103069</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0055">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0055">
<string-name>
<surname>Shibutani</surname>
<given-names>ST</given-names>
</string-name>, <string-name>
<surname>Saitoh</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nowag</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>MÃ¼nz</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Yoshimori</surname>
<given-names>T</given-names>
</string-name> (<year>2015</year>) <article-title>Autophagy and autophagyârelated proteins in the immune system</article-title>. <source>Nat Immunol</source>
<volume>16</volume>: <fpage>1014</fpage>â<lpage>1024</lpage>
<pub-id pub-id-type="pmid">26382870</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0056">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0056">
<string-name>
<surname>SÃ¶derberg</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Gullberg</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jarvius</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>RidderstrÃ¥le</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Leuchowius</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Jarvius</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wester</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hydbring</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Bahram</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Larsson</surname>
<given-names>LG</given-names>
</string-name>, <string-name>
<surname>Landegren</surname>
<given-names>U</given-names>
</string-name> (<year>2006</year>) <article-title>Direct observation of individual endogenous protein complexes inÂ situ by proximity ligation</article-title>. <source>Nat Methods</source>
<volume>3</volume>: <fpage>995</fpage>â<lpage>1000</lpage>
<pub-id pub-id-type="pmid">17072308</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0057">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0057">
<string-name>
<surname>Spira</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Benbassat</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Dormann</surname>
<given-names>A</given-names>
</string-name> (<year>1993</year>) <article-title>Resealing of the proximal and distal cut ends of transected axons: electrophysiological and ultrastructural analysis</article-title>. <source>J Neurobiol</source>
<volume>24</volume>: <fpage>300</fpage>â<lpage>316</lpage>
<pub-id pub-id-type="pmid">8492108</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0058">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0058">
<string-name>
<surname>Stewart</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Dykxhoorn</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Palliser</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Mizuno</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>EY</given-names>
</string-name>, <string-name>
<surname>An</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Sabatini</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>IS</given-names>
</string-name>, <string-name>
<surname>Hahn</surname>
<given-names>WC</given-names>
</string-name>, <string-name>
<surname>Sharp</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Weinberg</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Novina</surname>
<given-names>CD</given-names>
</string-name> (<year>2003</year>) <article-title>Lentivirusâdelivered stable gene silencing by RNAi in primary cells</article-title>. <source>RNA</source>
<volume>9</volume>: <fpage>493</fpage>â<lpage>501</lpage>
<pub-id pub-id-type="pmid">12649500</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0059">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0059">
<string-name>
<surname>SudriaâLopez</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Koppers</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>de Wit</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>van der Meer</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Westeneng</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Zundel</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Youssef</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Harkema</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>de Bruin</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Veldink</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>van den Berg</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>Pasterkamp</surname>
<given-names>RJ</given-names>
</string-name> (<year>2016</year>) <article-title>Full ablation of C9orf72 in mice causes immune systemârelated pathology and neoplastic events but no motor neuron defects</article-title>. <source>Acta Neuropathol</source>
<volume>132</volume>: <fpage>145</fpage>â<lpage>147</lpage>
<pub-id pub-id-type="pmid">27206760</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0060">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0060">
<string-name>
<surname>Sullivan</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Robins</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Paushter</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Smolka</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>F</given-names>
</string-name> (<year>2016</year>) <article-title>The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagyâlysosome pathway</article-title>. <source>Acta Neuropathol Commun</source>
<volume>4</volume>: <fpage>51</fpage>
<pub-id pub-id-type="pmid">27193190</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0061">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0061">
<string-name>
<surname>Suzuki</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>McHugh</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tork</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Shelley</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Klein</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Aebischer</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Svendsen</surname>
<given-names>CN</given-names>
</string-name> (<year>2007</year>) <article-title>GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS</article-title>. <source>PLoS One</source>
<volume>2</volume>: <fpage>e689</fpage>
<pub-id pub-id-type="pmid">17668067</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0062">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0062">
<string-name>
<surname>Tanida</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>MinematsuâIkeguchi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Ueno</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kominami</surname>
<given-names>E</given-names>
</string-name> (<year>2005</year>) <article-title>Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy</article-title>. <source>Autophagy</source>
<volume>1</volume>: <fpage>84</fpage>â<lpage>91</lpage>
<pub-id pub-id-type="pmid">16874052</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0063">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0063">
<string-name>
<surname>Thoreen</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Reichling</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Sim</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sabatini</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Gray</surname>
<given-names>NS</given-names>
</string-name> (<year>2009</year>) <article-title>An ATPâcompetitive mammalian target of rapamycin inhibitor reveals rapamycinâresistant functions of mTORC1</article-title>. <source>J Biol Chem</source>
<volume>284</volume>: <fpage>8023</fpage>â<lpage>8032</lpage>
<pub-id pub-id-type="pmid">19150980</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0064">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0064">
<string-name>
<surname>Topp</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Gray</surname>
<given-names>NW</given-names>
</string-name>, <string-name>
<surname>Gerard</surname>
<given-names>RD</given-names>
</string-name>, <string-name>
<surname>Horazdovsky</surname>
<given-names>BF</given-names>
</string-name> (<year>2004</year>) <article-title>Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor</article-title>. <source>J Biol Chem</source>
<volume>279</volume>: <fpage>24612</fpage>â<lpage>24623</lpage>
<pub-id pub-id-type="pmid">15033976</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0065">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0065">
<string-name>
<surname>Waite</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Baumer</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>East</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Neal</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>HR</given-names>
</string-name>, <string-name>
<surname>Ansorge</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Blake</surname>
<given-names>DJ</given-names>
</string-name> (<year>2014</year>) <article-title>Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion</article-title>. <source>Neurobiol Aging</source>
<volume>35</volume>: <fpage>1779.e5</fpage>â<lpage>1779.e13</lpage>
<pub-id pub-id-type="pmid">24559645</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0066">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0066">
<string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Menon</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yamasaki</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Chou</surname>
<given-names>HT</given-names>
</string-name>, <string-name>
<surname>Walz</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>FerroâNovick</surname>
<given-names>S</given-names>
</string-name> (<year>2013</year>) <article-title>Ypt1 recruits the Atg1 kinase to the preautophagosomal structure</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>110</volume>: <fpage>9800</fpage>â<lpage>9805</lpage>
<pub-id pub-id-type="pmid">23716696</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0067">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0067">
<string-name>
<surname>Winslow</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>CW</given-names>
</string-name>, <string-name>
<surname>Corrochano</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>AcevedoâArozena</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gordon</surname>
<given-names>DE</given-names>
</string-name>, <string-name>
<surname>Peden</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Lichtenberg</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Menzies</surname>
<given-names>FM</given-names>
</string-name>, <string-name>
<surname>Ravikumar</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Imarisio</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>O'Kane</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Rubinsztein</surname>
<given-names>DC</given-names>
</string-name> (<year>2010</year>) <article-title>alphaâSynuclein impairs macroautophagy: implications for Parkinson's disease</article-title>. <source>J Cell Biol</source>
<volume>190</volume>: <fpage>1023</fpage>â<lpage>1037</lpage>
<pub-id pub-id-type="pmid">20855506</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0068">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0068">
<string-name>
<surname>Xi</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Zinman</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Moreno</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Schymick</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ghani</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Dib</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Keith</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Robertson</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Rogaeva</surname>
<given-names>E</given-names>
</string-name> (<year>2013</year>) <article-title>Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion</article-title>. <source>Am J Hum Genet</source>
<volume>92</volume>: <fpage>981</fpage>â<lpage>989</lpage>
<pub-id pub-id-type="pmid">23731538</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0069">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0069">
<string-name>
<surname>Xiao</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>MacNair</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>McGoldrick</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>McKeever</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>McLean</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Keith</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zinman</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Rogaeva</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Robertson</surname>
<given-names>J</given-names>
</string-name> (<year>2015</year>) <article-title>Isoformâspecific antibodies reveal distinct subcellular localizations of C9orf72 in amyotrophic lateral sclerosis</article-title>. <source>Ann Neurol</source>
<volume>78</volume>: <fpage>568</fpage>â<lpage>583</lpage>
<pub-id pub-id-type="pmid">26174152</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0070">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0070">
<string-name>
<surname>Zhang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Iyer</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Aravind</surname>
<given-names>L</given-names>
</string-name> (<year>2012</year>) <article-title>Discovery of novel DENN proteins: implications for the evolution of eukaryotic intracellular membrane structures and human disease</article-title>. <source>Front Genet</source>
<volume>3</volume>: <fpage>283</fpage>
<pub-id pub-id-type="pmid">23248642</pub-id></mixed-citation>
      </ref>
      <ref id="embj201694401-bib-0071">
        <mixed-citation publication-type="journal" id="embj201694401-cit-0071">
<string-name>
<surname>Zu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>BanezâCoronel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Reid</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Pletnikova</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Lewis</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Harms</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Falchook</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Subramony</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Ostrow</surname>
<given-names>LW</given-names>
</string-name>, <string-name>
<surname>Rothstein</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Troncoso</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Ranum</surname>
<given-names>LP</given-names>
</string-name> (<year>2013</year>) <article-title>RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>110</volume>: <fpage>E4968</fpage>â<lpage>E4977</lpage>
<pub-id pub-id-type="pmid">24248382</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>